KR20090038260A - A method of intestinal delivery of therapeutic proteins using conditional suicide of genetically modified microorganisms - Google Patents

A method of intestinal delivery of therapeutic proteins using conditional suicide of genetically modified microorganisms Download PDF

Info

Publication number
KR20090038260A
KR20090038260A KR1020070103666A KR20070103666A KR20090038260A KR 20090038260 A KR20090038260 A KR 20090038260A KR 1020070103666 A KR1020070103666 A KR 1020070103666A KR 20070103666 A KR20070103666 A KR 20070103666A KR 20090038260 A KR20090038260 A KR 20090038260A
Authority
KR
South Korea
Prior art keywords
transformant
pastoris
promoter
strain
pichia
Prior art date
Application number
KR1020070103666A
Other languages
Korean (ko)
Other versions
KR100980411B1 (en
Inventor
우정희
강수현
강상기
최윤재
최승훈
김민경
Original Assignee
주식회사 인실리코텍
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 인실리코텍 filed Critical 주식회사 인실리코텍
Priority to KR1020070103666A priority Critical patent/KR100980411B1/en
Publication of KR20090038260A publication Critical patent/KR20090038260A/en
Application granted granted Critical
Publication of KR100980411B1 publication Critical patent/KR100980411B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/27Growth hormone [GH], i.e. somatotropin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/05Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/34Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormone [GH], i.e. somatotropin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/30Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A method for delivering therapeutic proteins using conditional suicide of genetically modified microorganisms to small intestine is provided to safely deliver therapeutic proteins to small intestine by using Pichia pastoris JW501 strain introduced with a catalytic domain gene of diphtheria toxin. A method for preparing Pichia pastoris transformant is to induce conditional suicide under the control of an AOX1 promoter by introducing a gene coding a catalytic domain 1-185 amino acid residue of diphtheria toxin to a wild type Pichia pastoris strain. The transformant additionally comprises an encoding gene of fusion protein consisting of the Fc domain of human growth hormone and human immunoglobulin 1, GAP promoter and alpha mating prepro secretional signal peptide. The conditional suicide occurs in the control condition of AOX1(alcohol oxidase 1) promoter which uses ethanol or glucose as a carbon source and is induced with formic acid of 0.075%.

Description

유전자 변형 미생물의 조건적 자살을 이용한 치료 단백질의 소장 전달방법{A method of intestinal delivery of therapeutic proteins using conditional suicide of genetically modified microorganisms}A method of intestinal delivery of therapeutic proteins using conditional suicide of genetically modified microorganisms}

본 발명은 유전자 변형 미생물의 조건적 자살을 이용한 치료 단백질의 소장 전달방법에 관한 것이다. 보다 상세하게는, 본 발명은 디프테리아 독소의 촉매 도메인 유전자와 치료 단백질로 재조합된 효모를 이용하여 특정 유도 조건 하에서 조건적으로 자살케 함으로써 소장 내에서 치료 단백질을 안전하게 분비할 수 있는 방법에 관한 것이다.The present invention relates to a method for intestinal delivery of therapeutic proteins using conditional suicide of genetically modified microorganisms. More specifically, the present invention relates to a method for safely secreting therapeutic proteins in the small intestine by conditionally suicide under specific induction conditions using yeast recombined with catalytic domain genes of diphtheria toxin and therapeutic proteins.

유전자 변형 미생물(GMMs)은 약제, 비타민과 효소의 생산, 생물적 환경 정화(bioremediation) 및 농업적 사용과 같이 다양하게 적용될 수 있다. 특히, 유전적으로 변형된 식음료용(food-grade) 미생물은 질병 치료와 면역 유도를 위해 치료 단백질을 점막으로 전달하는데 이용될 수 있다. 그러나, GMMs이 주위(environment)로 방출할 경우 그들이 생존 및 증식할 수 있고, 항생제 내성 유전자 또는 다른 유전자들을 전달함으로써 다른 미생물을 변형시킬 수도 있다. 영양요구성 균주(auxotrophic strain) 또는 독소 단백질을 조건적으로 발현하는 균주들은 GMMs의 확산을 억제하는데 사용되어 왔다. 이들 전략 중에서, 티미딜레이트 신타아제 유전자(thymidylate synthase gene), thyA가 결핍된 락토코커스 락티스(Lactococcus lactis)를 이용하여 티미딘 또는 티민 고갈 시 GMM의 사멸을 효과적으로 유도하였다. 더욱이, 인간 IL-10을 발현하는 티미딘 또는 티민 의존성 락토코커스 락티스(Lactococcus lactis) Thy12 균주는 크론병(Crohn's disease) 치료를 위한 임상 실험중에 있다. Genetically modified microorganisms (GMMs) can be used in a variety of applications, including the production of drugs, vitamins and enzymes, bioremediation and agricultural use. In particular, genetically modified food-grade microorganisms can be used to deliver therapeutic proteins to the mucosa for disease treatment and immune induction. However, when GMMs release to the environment, they can survive and proliferate, and can also modify other microorganisms by delivering antibiotic resistance genes or other genes. Auxotrophic strains or strains that conditionally express toxin proteins have been used to inhibit the spread of GMMs. Among these strategies, Timmy delay agent synthase gene (thymidylate synthase gene), the thyA deficient Lactococcus lactis (Lactococcus lactis ) effectively induced the death of GMM upon thymidine or thymine depletion. Further, thymine or thymidine dependence Lactococcus lactis (Lactococcus expressing human IL-10 lactis ) Thy12 strain is in clinical trials for the treatment of Crohn's disease.

비록 티미딘 또는 티민 의존성 재조합 락토코커스 락티스(Lactococcus lactis) 세균이 매력적이고 효과적인 봉쇄 시스템(containment system)을 가지고 있다고는 하나, 이종 단백질의 분비율이 낮아 이 기술을 거대 분자량을 가진 다른 치료 단백질의 소장 전달에 적용하기는 어렵다. Although thymidine or thymine-dependent recombinant Lactococcus lactis bacteria have an attractive and effective containment system, the secretion rate of heterologous proteins is low and the technique can be applied to other therapeutic proteins of large molecular weight. It is difficult to apply to small intestine delivery.

종래기술의 상기와 같은 한계를 극복하기 위해, 본 발명은 조건적으로 자살할 수 있는 피치아 파스토리스(Pichia pastoris)를 제공함을 목적으로 한다.In order to overcome the above limitations of the prior art, the present invention aims to provide Pichia pastoris capable of conditionally suicide.

본 발명의 다른 목적은 상기 형질전환체를 이용하여 치료 단백질을 소장으로 전달할 수 있는 방법을 제공하고자 한다.Another object of the present invention is to provide a method for delivering a therapeutic protein to the small intestine using the transformant.

본 발명의 상기 목적은 치료 단백질의 유전자와 디프테리아 독소의 촉매 도메인 유전자를 도입하여 유도 프로모터 AOX1의 조절 하에서 조건적으로 자살하는 피치아 파스토리스(Pichia pastoris)를 구축하고, 상기 형질전환체의 성장 프로파 일과 유전적 안정성을 조사하고, 유도 프로모터 AOX1의 유도 최적 조건을 조사하고, 상기 형질전환체의 치료 단백질의 분비 여부를 조사함으로써 달성하였다. The object of the present invention is to introduce a gene of a therapeutic protein and a catalytic domain gene of diphtheria toxin to construct Pichia pastoris which conditionally commits suicide under the control of the induction promoter AOX1, and the growth profile of the transformant This was achieved by investigating the file and genetic stability, investigating the optimal conditions for induction of the inducible promoter AOX1, and examining whether the transformant secreted the therapeutic protein.

본 발명의 특징은 유도 프로모터 AOX1(알코올 옥시다아제 1)의 조절 하에서 조건적 유도에 의한 미생물의 자살을 통해 치료 단백질을 소장으로 안전하게 전달하고, 유전자 변형 미생물의 생존과 증식을 억제하는 방법을 제공함을 특징으로 한다. A feature of the present invention is to provide a method for the safe delivery of therapeutic proteins to the small intestine through the suicide of microorganisms by conditional induction under the control of the inducible promoter AOX1 (alcohol oxidase 1), and to provide a method for inhibiting the survival and proliferation of genetically modified microorganisms. It is done.

본 발명의 미생물의 조건적 자살에 사용되는 미생물은 피치아 파스토리스(Pichia pastoris)이며, 조건적 자살을 위해서는 디프테리아 독소의 촉매 도메인을 사용하였다. 한 개의 활성분자는 한 개의 세포를 죽이는데 충분하기 때문에 조건적 유도에 의한 촉매 도메인의 세포 내 발현을 통해 세포를 죽일 수 있다. 게다가, 디프테리아 독소의 촉매 도메인은 신장인자-2(Elongation Factor-2, EF-2)의 ADP-라이보실화(ADP-ribosylation)에 의해 진핵세포의 단백질 합성을 불활성화하기 때문에, 활성 촉매 도메인의 발현은 단백질 합성을 즉시 차단할 것이며, 결과적으로 세포내에 미량의 촉매 도메인만 축적될 것이다. 또한 분비 시그널 서열을 가지고 있지 않기 때문에, 시토졸에서 배양 배지 또는 인간과 가축의 소장으로 촉매 도메인의 우연한 탈출은 일어나지 않는다. 따라서, 촉매 도메인은 세포와 결합할 수 없고 시토졸로 이동할 수도 없어 탈출한 촉매 도메인은 인간과 가축에 해롭지 않다. The microorganism used for the conditional suicide of the microorganism of the present invention is Pichia pastoris , and the catalytic domain of diphtheria toxin was used for the conditional suicide. Since one active molecule is sufficient to kill one cell, it can kill the cell through intracellular expression of the catalytic domain by conditional induction. In addition, since the catalytic domain of diphtheria toxin inactivates protein synthesis in eukaryotic cells by ADP-ribosylation of Elongation Factor-2 (EF-2), Expression will immediately block protein synthesis and consequently accumulate only trace amounts of catalytic domains within the cell. Also, because it does not have a secretory signal sequence, no accidental escape of the catalytic domain from the cytosol to the culture medium or the small intestine of humans and livestock occurs. Thus, the escaped catalytic domain is not harmful to humans and livestock because the catalytic domain cannot bind to the cell and cannot migrate to the cytosol.

본 발명자들은 다음과 같은 이유로 치료 단백질의 소장으로의 전달을 위한 도구로 피치아 파스토리스(Pichia pastoris)를 선택하였다:We chose Pichia pastoris as a tool for delivery of therapeutic proteins to the small intestine for the following reasons:

a) 엔도톡신과 리트로 바이러스가 없음,a) free of endotoxin and retrovirus,

b) 효과적인 단백질 분비능,b) effective protein secretion,

c) 높은 세포 밀도에서 배양될 수 있음(30~40%),c) can be cultured at high cell density (30-40%),

d) 사카로마이세스 세레비지에(Saccharomyces cerevisiae) 처럼 유전적으로 안전한 것으로 간주됨(generally recognized as safe, GRAS),d) Saccharomyces cerevisiae ), generally recognized as safe (GRAS),

e) 강력한 유도 프로모터(알코올 옥시다아제 1)가 있음,e) has a strong inducible promoter (alcohol oxidase 1),

f) 디프테리아 독소에 대해 비교적 내성이 있음.f) relatively resistant to diphtheria toxin.

디프테리아 독소에 대한 내성 때문에, 본 발명자들은 조건적으로 자살할 수 있는 피치아 파스토리스(Pichia pastoris)를 개발하는데 성공하였다.Because of their resistance to diphtheria toxins, the inventors have succeeded in developing Pichia pastoris that can conditionally commit suicide.

본 발명의 조건적으로 자살할 수 있는 피치아 파스토리스(Pichia pastoris) 형질전환체는 디프테리아 독소의 촉매 도메인 1~185 아미노산 잔기를 코딩하는 유전자, 인간의 성장 호르몬과 인간의 면역글로불린 1의 Fc 영역으로 구성된 융합 단백질의 코딩유전자, GAP 프로모터 및 알파 메이팅 프리프로 분비 시그널 펩티드(alpha mating prepro secretional signal peptide)을 포함함을 특징으로 한다.Conditionally suicide of the present invention Pichia Pastoris pastoris ) transformants secrete coding genes, GAP promoters and alpha mating prepros, of genes encoding catalytic domains 1-185 amino acid residues of diphtheria toxin, fusion proteins consisting of human growth hormone and Fc regions of human immunoglobulin 1 It is characterized in that it comprises a signal peptide (alpha mating prepro secretional signal peptide).

본 발명에서는 유도 프로모터 AOX1(알코올 옥시다아제 1)의 조절 하에서 형질전환체의 조건적 자살을 구현하였다. In the present invention, the conditional suicide of the transformant was implemented under the control of the inducible promoter AOX1 (alcohol oxidase 1).

신규 균주인 JW501 균주는 유도인자인 메탄올의 유무에 상관없이 효모 추출물이 있어야 생존하였다. 따라서, 유전자 변형 미생물을 봉쇄하기 위한 도구로 사용될 수 있는데 이는 JW501 균주가 하수 처리용 정화조의 엄격한 조건 하에서 생존할 수 없을 것이기 때문이다.The new strain, JW501, survived only with the presence of yeast extract with or without methanol, the inducer. Therefore, it can be used as a tool for containment of genetically modified microorganisms because the JW501 strain will not be able to survive under the strict conditions of the septic tank for sewage treatment.

또한, 메탄올의 2차 대사산물인 포름산(formic acid)은 GMMs를 조절하기 위한 부가 수단을 제공할 경우 조건적으로 자살할 수 있는 피치아 파스토리스(Pichia pastoris)를 0.075%로 선택적으로 죽였다. 이러한 신규 균주인 JW501 생존에 대한 메탄올의 2차 대사산물인 포름산(formic acid)의 선택적 사멸 효과는 유전자 변형 미생물의 확산을 억제할 수 있는 실마리를 제공할 것으로 사료된다.In addition, the secondary (formic acid) metabolite formic acid in methanol when to provide additional means for regulating the GMMs conditional to avoid suicide Chiapas Laboratories in the (Pichia pastoris ) was selectively killed at 0.075%. The selective killing effect of formic acid, a secondary metabolite of methanol, on the survival of this new strain, JW501, is thought to provide clues to inhibit the spread of genetically modified microorganisms.

더욱이, 신규 균주인 JW501은 고분자량의 치료 단백질을 분비할 수 있는 능력을 보유하고 있다.Moreover, the new strain JW501 has the ability to secrete high molecular weight therapeutic proteins.

따라서, 본 발명은 GMMs의 봉쇄와 치료 단백질의 소장 전달을 위한 효과적인 방법을 제공한다.Thus, the present invention provides an effective method for blockade of GMMs and small intestinal delivery of therapeutic proteins.

이하, 본 발명이 구체적인 방법을 실시예를 들어 상세히 설명하고자 하지만 본 발명의 권리범위는 이들 실시예에만 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail by way of examples, but the scope of the present invention is not limited only to these examples.

본 발명은 유전자 변형 미생물의 조건적 자살을 이용한 치료 단백질의 소장 전달방법에 관한 것으로, 유도 프로모터 AOX1 조절 하에서 조건적으로 자살할 수 있고 치료 단백질을 발현할 수 있는, 디프테리아 독소의 촉매 도메인 유전자가 도입된 피치아 파스토리스(Pichia pastoris) JW501 균주를 제공하는 뛰어난 효과가 있다. 본 발명은 상기 균주를 이용함으로써 치료 단백질을 소장에 안전하게 전달할 수 있고 유전자 변형 미생물을 봉쇄할 수 있는 효과적인 방법을 제공하는 뛰어난 효과가 있다. 따라서, 본 발명은 제약산업상 매우 유용한 발명인 것이다.The present invention relates to a small intestine delivery method of a therapeutic protein using conditional suicide of a genetically modified microorganism, wherein a catalytic domain gene of diphtheria toxin, which can conditionally suicide under the control of an inducible promoter AOX1 and express a therapeutic protein, is introduced. There is an excellent effect of providing the strained Pichia pastoris JW501 strain. The present invention has an excellent effect of providing an effective method to safely deliver a therapeutic protein to the small intestine and to block genetically modified microorganisms by using the strain. Therefore, the present invention is a very useful invention in the pharmaceutical industry.

이하 실시예를 통하여 본 발명을 자세히 설명하고자 하지만 이들 실시예는 본 발명을 보다 구체적으로 설명하기 위한 것으로 본 발명의 범위가 이들 실시예에 의해 제한되지 않는다.Hereinafter, the present invention will be described in detail with reference to the following examples, which are intended to explain the present invention in more detail, and the scope of the present invention is not limited to these examples.

실시예Example 1: 조건적으로 자살하는  1: conditionally committing suicide 피치아Peachia 파스토리스Pastoris (( PichiaPichia pastorispastoris ) ) JW501JW501 의 제조Manufacture

디프테리아 독소의 촉매 도메인이 시토졸에서 발현하여 조건적으로 자살하는 피치아 파스토리스(Pichia pastoris)를 제조하기 위해, N-말단측에 부가적인 메티오닌 잔기를 갖고 있는 디프테리아 독소의 촉매 도메인(잔기 1~185)의 유전자를 PCR 증폭하여 pPIC3 벡터를 구축하였다.The catalytic domain of diphtheria toxin, which has an additional methionine residue on the N-terminus side, to prepare Pichia pastoris , in which the catalytic domain of diphtheria toxin is expressed in the cytosol and conditionally suicides (residue 1 ~ 185) gene was amplified by PCR to construct pPIC3 vector.

유전자조작을 위한 숙주로서 에스케리치아 콜라이(Escherichia coli) Nova Blue 균주(노바젠, 미국 매디슨)를 사용하였고, 저염 LB 배지에서 배양하였다(1% 트립톤, 0.5% 효모 추출물, 0.5% NaCl; 플레이트 경우 2% 아가; 플라스미드 선별을 위해서는 50㎍/㎖ 앰피실린 또는 25㎍/㎖의 제오신을 사용함). Escherichia as a Host for Genetic Engineering coli ) Nova Blue strain (Novazen, Madison, USA) was used and cultured in low salt LB medium (1% tryptone, 0.5% yeast extract, 0.5% NaCl; 2% agar for plates; 50 μg / for plasmid selection) Ml ampicillin or 25 μg / ml zeosin).

촉매 도메인 유전자는 주형 DNA로 최대한 활용화되어 있는 DT390(디프테리아 독소의 1~390의 아미노산 잔기들)을 이용하여 증폭하였으며, 프라이머는 다음과 같다: The catalytic domain gene was amplified using DT390 (1 to 390 amino acid residues of diphtheria toxin), which is fully utilized as template DNA, and the primers are as follows:

정방향 프라이머: 5'-atgttcgaaacgATGGCTGGCGCTGATGATGTCGTC-3'Forward primer: 5'-atg ttcgaa acgATGGCTGGCGCTGATGATGTCGTC-3 '

역방향 프라이머: 5'-atggaattctcaGGCTTGAGCCATATACTCATA-3'Reverse primer: 5'-atg gaattc tcaGGCTTGAGCCATATACTCATA-3 '

PCR 산물을 증폭하기 위하여 94℃에서 2분간 denaturing한 다음 30회의 증폭 싸이클 (94℃에서 30초, 50℃에서 30초, 72℃에서 1분)을 실시하고, 72℃에서 7분동안 반응시킨 다음 PCR 반응을 종료하였다. 그 후, PCR 산물은 SfuI 과 EcoRI으로 절단하였다. 최종 DNA 단편은 SfuI, EcoRI 및 CIP(calf intestinal phosphatase)를 처리한 pnPICZα 벡터에 라이게이션 시켰다. 상기 유전자 구축물로부터, 촉매 도메인 유전자를 포함하는 SacI과 EcoRI로 절단된 작은 단편을 SacI, EcoRI 및 CIP를 처리한 pPIC3 벡터(도 1의 개열지도와 서열 1 참조)에 서브클로닝하였다.To amplify the PCR product, denaturing at 94 ° C for 2 minutes, followed by 30 amplification cycles (30 seconds at 94 ° C, 30 seconds at 50 ° C, 1 minute at 72 ° C), and reacting at 72 ° C for 7 minutes The PCR reaction was terminated. Thereafter, PCR products were digested with Sfu I and EcoR I. The final DNA fragment was ligated to pnPICZα vector treated with Sfu I, EcoR I and cal intestinal phosphatase (CIP). From the gene construct, Small fragments digested with Sac I and EcoR I containing catalytic domain genes were subcloned into pPIC3 vectors (see cleavage map of FIG. 1 and SEQ ID NO: 1) treated with Sac I, EcoR I and CIP.

다음으로, hGH-Fc 융합 단백질의 발현을 위해 hGH-Fc 융합 단백질의 유전자를 pGAPZα 벡터에 구축하였다. 상기 단백질은 인간 성장 호르몬과 인간 IgG1의 Fc 영역으로 구성되어 있으며, 세포 밖에서 이량체 형태로 발현된다. 우선, 선행연구(대한민국 등록특허 제10-0594607호)에서 제조한 hGH-Fc 융합 단백질의 발현을 위한 hGH-h-Fc 유전자 구축물을 BstBI과 EcoRI으로 절단하였다. hGH-Fc 유전자를 포함하는 작은 단편을, JW501 균주를 형질전환하기 위해 사용되는 BstBI, EcoRI 및 CIP를 처리한 pGAPZα 벡터(도 2의 개열지도와 서열 2 참조)에 클로닝하였다. Next, a gene of the hGH-Fc fusion protein was constructed in the pGAPZα vector for expression of the hGH-Fc fusion protein. The protein consists of the human growth hormone and the Fc region of human IgG1 and is expressed in dimeric form outside the cell. First, hGH-h-Fc gene constructs for the expression of hGH-Fc fusion protein prepared in the previous study (Korean Patent No. 10-0594607) were cut with BstB I and EcoR I. the small fragment containing the hGH-Fc gene was cloned into the BstB I, pGAPZα vector treated with EcoR I and CIP (see Fig cleavage map and sequence 2 of 2) which is used to transform the strain JW501.

다음으로, 10㎍의 플라스미드는 SacI을 이용하여 선형으로 만들고 나서, 200W, 7,500V/cm 및 25μF의 Bio-Rad Gene Pulser Xcell electroporation system(바이오래드 래보러토리스, 미국 허큘리스)를 이용하여 일렉트로포레이션으로 피치아 파스토리스(Pichia pastoris) GS115 균주((Mut+ His-, 인비트로젠, 미국 칼스바드)에 삽입하였다. 형질전환체들은 히스티딘-결핍 RD 아가 플레이트(1M 솔비톨, 2% 덱스트로우즈, 1.34% 아미노산이 없는 효모 질소 염기, 4×10-5% 바이오틴, 및 0.005% 아미노산 혼합물; 플레이트의 경우 2% 아가) 또는 100㎍/㎖의 제오신(인비트로젠)을 포함하는YPD 아가 플레이트(1% 효모 추출물, 2% 펩톤 및 2% 덱스트로우즈; 플레이트의 경우 2% 아가)에서 선별하였다.Next, 10 μg of the plasmid was made linear using Sac I, followed by electrophoresis using a Bio-Rad Gene Pulser Xcell electroporation system (Biorad Laboratories, Hercules, USA) at 200 W, 7,500 V / cm and 25 μF. Pichia Pastoris ( Pichia) pastoris) GS115 strains were inserted ((Mut + His, Invitrogen, USA Carlsbad) transformants are histidine-deficient RD agar plates (1M sorbitol, 2% dextrose woods, without 1.34% amino yeast nitrogen YPD agar plate (1% yeast extract, 2%) containing base, 4 × 10 −5 % biotin, and 0.005% amino acid mixture; 2% agar for plate) or 100 μg / ml zeocin (Invitrogen) Peptone and 2% dextrose; 2% agar for plates).

다음으로, 피치아 파스토리스(Pichia pastoris)의 메탄올 유도 배양을 위해 한 개의 콜로니를 14㎖의 스냅-캡 테스트 튜브에서 5㎖의 YPD 브로스에서 28℃에서 250rpm(궤도 직경, 1.9cm)으로 2일간 배양하고, 3㎖의 BMMY 브로스(1% 효모 추출물, 2% 펩톤, 100mM 포타슘 포스페이트, pH7.0, 1.34% 아미노산이 없는 효모 질소 염기, 4×10-5% 바이오틴, 0.5% 메탄올 및 1% 카사미노산)에서 재현탁하고, 24시간 마다 15㎕의 메탄올을 첨가하여 1~2일 동안 유도하였다.Next, one colony for methanol-induced cultivation of Pichia pastoris in 250 ml (orbit diameter, 1.9 cm) at 28 ° C. in 5 ml YPD broth in a 14 ml snap-cap test tube. Incubate 3 ml of BMMY broth (1% yeast extract, 2% peptone, 100 mM potassium phosphate, pH7.0, yeast nitrogen base without 1.34% amino acid, 4 × 10-5 % biotin, 0.5% methanol and 1% casa) Resuspended in mino acid) and induced for 1 to 2 days by adding 15 μl of methanol every 24 hours.

구성적 발현을 위해서는, 피치아 파스토리스(Pichia pastoris)의 콜로니 한 개를 14㎖의 스냅-캡 테스트 튜브에서 5㎖의 YPD 브로스에서 28℃에서 250rpm(궤도 직경, 1.9cm)으로 1~2일간 배양하고, 배양 상등액을 분석하였다.For constitutive expression, one colony of Pichia pastoris was placed at 250 rpm (orbit diameter, 1.9 cm) at 28 ° C. in 5 ml YPD broth in a 14 ml snap-cap test tube for 1-2 days. Cultures and culture supernatants were analyzed.

유전자 산물은 메탄올-유도 AOX1(알코올 옥시다아제 1) 프로모터의 조절 하에서 세포 내에서 발현되었다. 메탄올이 없는 경우에서도 AOX1 프로모터는 매우 미약한 수준으로 발현을 유도되는 것으로 알려져 있고, 이렇게 발현되는 촉매 도메인의 심각한 독성 때문에, 단지 3개의 형질전환체를 얻었다. Gene products were expressed in cells under the control of the methanol-induced AOX1 (alcohol oxidase 1) promoter. Even in the absence of methanol, the AOX1 promoter is known to induce expression at very slight levels, and because of the severe toxicity of the catalytic domain so expressed, only three transformants were obtained.

조건적 자살을 확인하기 위해, 상기 형질전환체들을 유도인자인 메탄올을 포함하는 최소배지 MM 아가 플레이트(1.34% 아미노산이 없는 효모 질소 염기, 4×10-5% 바이오틴, 0.5% 메탄올 및 2% 아가)에 평판배양하였다.To confirm the conditional suicide, the transformants were subjected to a minimal medium MM agar plate (1.34% amino acid free yeast nitrogen base, 4 × 10 −5 % biotin, 0.5% methanol and 2% agar) containing inducer methanol. Plate).

예상대로, 모든 형질전환체들은 독성의 촉매 도메인을 발현하여 MM 아가 플레이트에서는 전혀 생장하지 않았다. 또한, 웨스턴 블랏팅 결과, 1일 또는 2일간 유도시킨 배양액의 상등액에서 촉매 도메인의 어떠한 밴드도 검출되지 않았다(미도시됨). 그들 중 한 개의 형질전환체를 선택하고 JW501로 명명하였다. 상기 형질전환체 JW501은 2007년 10월 1일자로 한국생명공학연구원내의 생물자원센터(KCTC)에 기탁하고 기탁번호 KCTC 11208BP를 부여받았다.As expected, all transformants expressed a toxic catalytic domain and did not grow at all on MM agar plates. In addition, Western blotting revealed no bands of the catalytic domains in the supernatants of the cultures induced for 1 or 2 days (not shown). One of them was selected and named JW501. The transformant JW501 was deposited on October 1, 2007, at the KCTC in the Korea Research Institute of Bioscience and Biotechnology and was assigned accession number KCTC 11208BP.

실험예Experimental Example 1:  One: JW501JW501 균주의 성장 프로파일과 유전적 안정성 Growth profile and genetic stability of the strain

어느 조건이 효과적인 세포 사멸을 유도하였는지를 측정하기 위해 탄소원으로 메탄올 또는 글루코오스를 포함하는 여러 아가 플레이트에서 신규 균주 JW501의 성장 프로파일을 조사하였다. 피치아 파스토리스(Pichia pastoris) X-33 균주(Mut+, 인비트로젠, 미국 칼스바드)을 대조군으로 사용하였다. The growth profile of the new strain JW501 was examined in several agar plates containing methanol or glucose as the carbon source to determine which condition induced effective cell death. Pichia Pastoris pastoris ) X-33 strain (Mut + , Invitrogen, Carlsbad, USA) was used as a control.

세포 성장을 측정하기 위해 세포밀도(wet cell density, %, w/v)를 측정하였다. 효모 균주의 성장 프로파일을 측정하기 위해서는 MM 아가 플레이트(1.34% 아미노산이 없는 효모 질소 염기, 4×10-5% 바이오틴, 0.5% 메탄올 및 2% 아가) 또는 MD 아가 플레이트(1.34% 아미노산이 없는 효모 질소 염기, 4×10-5% 바이오틴, 2% 덱스트로우즈 및 2% 아가)를 사용하였다.Wet cell density (%, w / v) was measured to measure cell growth. To determine the growth profile of the yeast strain, MM agar plates (yeast nitrogen base without 1.34% amino acid, 4 × 10 −5 % biotin, 0.5% methanol and 2% agar) or MD agar plates (yield without 1.34% amino acid) Base, 4 × 10 −5 % biotin, 2% dextrose and 2% agar).

미리 무게를 측정한 1.5㎖-마이크로원심분리기용 튜브에 1㎖의 배양 시료를 주입하고, 20,800×g, 25℃에서 2분간 원심분리하였다. 상등액은 피펫으로 제거하 고, 튜브 내에 남아있는 액체는 여과지로 제거하였다. 세포 펠릿을 포함하는 튜브의 무게를 잰 후, 세포밀도(%, w/v)를 계산하였다.1 ml of the culture sample was injected into a previously weighed 1.5 ml-microcentrifuge tube, and centrifuged at 20,800 × g and 25 ° C. for 2 minutes. The supernatant was removed by pipette and the remaining liquid in the tube was removed by filter paper. After weighing the tube containing the cell pellet, the cell density (%, w / v) was calculated.

스팟 분석을 위해서는, 다양한 배지 성분들을 포함하는 아가 플레이트 상에서 성장 프로파일을 비교하기 위해, 시험 균주들을 5㎖의 YPD 배지에서 28℃, 250rpm 조건으로 30시간 동안 배양하였다. 각 배양액의 흡광도는 600nm에서 측정하였다. 배양액은 OD600에서 2.0이 되도록 PBS(phosphate buffered saline), pH7.4로 조정하였다. 5배씩 연속 희석하고(OD600이 2.0, 0.4, 0.08, 0.016, 0.032, 및 0.00064이 되도록 함), 4㎕의 희석 배양액을 다양한 아가 플레이트에 스팟팅하였다. 스팟 콜로니가 나타날 때까지 상기 플레이트를 28℃에서 2~4일 동안 배양하고 그 결과를 도 3에 나타내었다. 도 3에서 MM은 최소 메탄올 배지, MD는 최소 덱스트로우즈 배지, YMM은 MM+1% 효모 추출물을 의미한다.For spot analysis, test strains were incubated for 30 hours at 28 ° C., 250 rpm in 5 ml of YPD medium to compare growth profiles on agar plates containing various media components. The absorbance of each culture was measured at 600 nm. The culture was adjusted to phosphate buffered saline (PBS), pH 7.4 to 2.0 at OD 600 . Five dilutions were serially diluted (so that the OD 600 was 2.0, 0.4, 0.08, 0.016, 0.032, and 0.00064) and 4 μl of diluted culture was spotted onto various agar plates. The plates were incubated at 28 ° C. for 2-4 days until spot colonies appeared and the results are shown in FIG. 3. In FIG. 3, MM means minimum methanol medium, MD means minimum dextrose medium, and YMM means MM + 1% yeast extract.

스팟 분석에서, 메탄올 또는 글루코오스를 포함하는 최소배지 아가 플레이트는 JW501의 완전한 사멸을 유도하였다(도 3). 그러나, 1% 효모 추출물(w/v)과 메탄올을 포함하는 최소배지에서는 JW501의 사멸을 유도하는 데 실패하였으며, 이는 효모 추출물이 디프테리아 독소에 대한 어떤 보호적인 능력을 가지고 있음을 시사하는 것이다.In spot analysis, minimal medium agar plates containing methanol or glucose induced complete killing of JW501 (FIG. 3). However, the minimal medium containing 1% yeast extract (w / v) and methanol failed to induce the death of JW501, suggesting that the yeast extract has some protective capacity against diphtheria toxin.

본 발명의 신규 균주인 JW501의 경우, 메탄올에 의해 엄격하게 조절되는 것으로 알려져 있는 AOX1 프로모터의 조절 하에서 세포 내에서 발현된다. In the case of JW501, a novel strain of the invention, it is expressed in cells under the control of the AOX1 promoter, which is known to be tightly regulated by methanol.

글리세롤이 있는 경우, AOX1 프로모터에 의한 AOX1의 mRNA는 노던 블랏에서 는 검출되지 않는다. 그러나, 탄소원이 없는 경우, 노던 블랏에서 낮은 수준으로 AOX1의 mRNA가 검출된다. 따라서, 본 발명자들은 글리세롤 및/또는 글루코오스의 존재는 디프테리아 독소의 촉매 도메인의 독성을 차단할 것으로 예측하였으나, 글리세롤과 글루코오스는 JW501 균주의 성장에 영향을 주지 않았다. 이는 한 개의 활성물질로도 세포를 죽이는 충분하다는 촉매 도메인의 특성과 관련이 있을 것이다. 비록 글리세롤이 있는 경우 AOX1의 mRNA가 노던 블랏에서는 검출되지 않았을지라도, 검출할 수 없는 정도로 극소량의 mRNA라도 한 개의 활성 촉매 도메인을 합성하는데는 충분하다. 따라서, 글루코오스 아가 플레이트에서 JW501 균주가 성장하지 않을 수 있다.In the presence of glycerol, mRNA of AOX1 by the AOX1 promoter is not detected in the northern blot. However, in the absence of a carbon source, low levels of AOX1 mRNA are detected in the northern blot. Thus, we predicted that the presence of glycerol and / or glucose would block the toxicity of the catalytic domain of diphtheria toxin, but glycerol and glucose did not affect the growth of the JW501 strain. This may be related to the nature of the catalytic domain that one active substance is sufficient to kill cells. Although in the presence of glycerol the mRNA of AOX1 was not detected in the Northern blot, even an undetectable amount of mRNA is sufficient to synthesize one active catalytic domain. Thus, the JW501 strain may not grow in glucose agar plates.

대신에 효모 추출물은 피치아 파스토리스(Pichia pastoris)에서 촉매 도메인에 대해 보호 활성을 나타냈다. 선행연구에서 본 발명자들은 야생형 피치아 파스토리스(Pichia pastoris)에서 항-T 세포 면역적 독소를 생산하기 위한 메탄올 유도 동안, 효모 추출물을 계속적으로 투입할 경우 면역적 독소의 독성을 감쇄시킴을 관찰한바 있다. 디프테리아 독소는 3개의 도메인으로 구성되어 있다: 촉매 도메인, 전좌(translocation) 도메인 및 인지(recognition) 도메인. 진핵세포를 죽이기 위해, 우선 디프테리아 독소의 인지 도메인을 세포 표면의 헤파린 바인딩 EGF-유사 수용체에 결합시킨다. 이 결합은 수용체에 의한 엔도사이토시스를 유도하고 다음으로 엔도좀으로의 빠른 로컬리제이션을 유발한다. 독소의 전좌 도메인은 엔도좀의 산성 환경에서 모양을 바꾸어 엔도좀 막으로 삽입케 한다. 전좌 도메인은 시토졸의 Hsp90과 티오레독신 리덕타아제와 상호작용하여 촉매 도메인을 시토졸로 위치를 이 동시킨다. 이동된 촉매 도메인은 다시 접히고 EF-2의 ADP-라이보실화에 따라 세포 내 단백질의 합성을 효소적으로 불활성화시킨다. 이러한 독성화(intoxication) 메커니즘에 있어서, 몇몇 억제제들이 보고되어 있다. 암모늄 클로라이드와 모넨신은 위치 이동 과정에서 어떤 단계를 억제하여 엔도좀 또는 클로로퀸의 산성화를 억제한다. 결과적으로, 촉매 도메인의 엔도좀에서 시토졸로의 위치 이동은 실패하게 된다. 그러나, 촉매 도메인의 억제 활성은 보고된 바 없다. 따라서, 본 발명자들은 효모 추출물은 수많은 저분자 펩타이드들을 가지고 있기 때문에 한 개 또는 몇 개의 펩티드들은 촉매 도메인의 효소 활성을 억제할 것임을 추측할 수 있었다. Instead, yeast extract showed protective activity against catalytic domain in Pichia pastoris . In a previous study, the inventors observed that continuous application of yeast extract attenuated the toxicity of immune toxins during methanol induction to produce anti-T cell immune toxins in wild-type Pichia pastoris . have. Diphtheria toxin consists of three domains: catalytic domain, translocation domain and recognition domain. To kill eukaryotic cells, the cognitive domain of diphtheria toxin is first bound to a heparin binding EGF-like receptor on the cell surface. This binding induces endocytosis by the receptor followed by rapid localization to the endosomes. The translocation domain of the toxin changes shape in the acidic environment of the endosome and inserts it into the endosome membrane. The translocation domain interacts with Hsp90 and thioredoxin reductase of the cytosol to relocate the catalytic domain to the cytosol. The migrated catalytic domains refold and enzymatically inactivate the synthesis of intracellular proteins following ADP-ribosylation of EF-2. In this intoxication mechanism, several inhibitors have been reported. Ammonium chloride and monensin inhibit certain steps in the site shift process to inhibit acidification of endosomes or chloroquines. As a result, the position shift from the endosome of the catalytic domain to the cytosol fails. However, no inhibitory activity of the catalytic domain has been reported. Thus, the inventors could infer that since the yeast extract has numerous low molecular peptides, one or several peptides will inhibit the enzymatic activity of the catalytic domain.

한편, 담즙산염은 종종 프로바이오틱 용도의 젖산균의 성장을 지연하기 때문에, 담즙산염이 JW501 균주의 성장을 지연시키는지를 시험하였다. 담즙산염의 소스로 옥스갈 추출물(oxgall extract)을 사용하였다. 0~1.0% 농도의 옥스갈 추출물을 포함하는 5㎖의 YPD 배지에 30시간 배양된 JW501 배양액을 3회 반복으로 접종하였다. 세포밀도는 시간대별로 측정하였고 도 4에 그 결과를 나타내었다. 오차 막대는 SD(표준편차)를 나타낸다.On the other hand, since bile salts often delay the growth of lactic acid bacteria for probiotic use, it was tested whether bile salts delayed the growth of JW501 strains. Oxgall extract was used as a source of bile salts. JW501 cultures incubated for 30 hours were inoculated three times in 5 ml of YPD medium containing 0-1.0% oxalic extract. Cell density was measured by time zone and the results are shown in FIG. 4. Error bars represent SD (standard deviation).

도 4에 나타난 바와 같이, 옥스갈 추출물은 0~1.0%(w/v) 범위에서는 JW501 균주의 성장에 영향을 미치지 않았다.As shown in Figure 4, oxgal extract did not affect the growth of JW501 strain in the range of 0 ~ 1.0% (w / v).

JW501 균주의 유전적 안정을 조사하기 위해 YPD 아가 플레이트에서 계대배양하였다. JW501 균주를 계대배양하기 위해, 형질전환체 스크리닝용 선택 아가 플레이트 상의 초기 콜로니를 패시지 1번으로 정하였다. 이 콜로니를 신선한 YPD 아가 플레이트 상에서 스트리킹하고 28℃에서 2일간 배양하였다. 잘 분리된 콜로니(패시 지 2번)를 무작위로 픽킹하고 다른 신선한 YPD 아가 플레이트 상에서 스트리킹한 다음 배양하였다. 패시지 번호가 60번인 JW501 콜로니를 얻을 때까지 이러한 계대배양을 60회 반복하였다. 계대배양을 위한 각각의 YPD 플레이트에서 얻은 한 개의 콜로니에 대해 글루코오스를 포함하는 최소배지 아가 플레이트에서 성장 프로파일을 조사하였다. Passage was cultured on YPD agar plates to investigate the genetic stability of the JW501 strain. To passage the JW501 strain, initial colonies on the selection agar plates for transformant screening were designated as passage number 1. This colony was streaked on fresh YPD agar plates and incubated at 28 ° C. for 2 days. Well separated colonies (passage 2) were randomly picked and streaked on other fresh YPD agar plates and incubated. This passage was repeated 60 times until a JW501 colony with passage number 60 was obtained. One colony from each YPD plate for subculture was examined for growth profiles in minimal medium agar plates containing glucose.

시험한 모든 콜로니들은 최소배지 아가 플레이트에서 성장하지 않았다. 이는 비록 JW501 균주가 디프테리아 독소의 촉매 도메인의 독성 유전자를 가지고 있다고 하여도 유전적으로 안정함을 시사하는 것이다.All colonies tested did not grow on minimal medium agar plates. This suggests that the JW501 strain is genetically stable even if it contains the virulence gene of the catalytic domain of diphtheria toxin.

실험예Experimental Example 2:  2: AOX1AOX1 프로모터의 유도 조건 Promoter condition of promoter

포름산과 과산화수소는 피치아 파스토리스(Pichia pastoris)의 메탄올 대사에서 2차 대사산물이기 때문에, 포름산 또는 과산화수소가 AOX1 프로모터를 유도하는 지를 조사하였다. Since formic acid and hydrogen peroxide are secondary metabolites in the methanol metabolism of Pichia pastoris , we investigated whether formic acid or hydrogen peroxide induces the AOX1 promoter.

이를 위해, hGH-Fc 융합 단백질을 발현하는 피치아 파스토리스(Pichia pastoris) 형질전환체(H6 균주, Lee, C. H. et al. 2007. Expression and characterization of human growth hormone-Fc fusion proteins for transyctosis induction. Biotechnol . Appl . Biochem . 46(4):211-217.)를 사용하였다. H6 균주를 이용하여, 포름산, 포름산과 덱스트로우즈, 과산화수소, 또는 과산화수소와 덱스트로우즈를 포함하는 다양한 유도 배지에서 발현 수준을 비교하였다. 메탄올은 AOX1 프로모터에 대한 유도인자로 알려져 있고, 덱스트로우즈는 AOX1 프로모터를 억제하 기 때문에, 메탄올과 덱스트로우즈는 각각 양성 및 음성 대조군으로 사용하였다. To this end, the blood hGH-Fc fusion protein expressing Chiapas pastoris (Pichia pastoris) transformants (H6 strain, Lee, CH et al. 2007. Expression and characterization of human growth hormone-Fc fusion proteins for transyctosis induction. Biotechnol ... Appl Biochem 46 (4 ): 211-217 was used). H6 strains were used to compare expression levels in various induction media including formic acid, formic acid and dextrose, hydrogen peroxide, or hydrogen peroxide and dextrose. Since methanol is known as an inducer for the AOX1 promoter, and dextrose inhibits the AOX1 promoter, methanol and dextrose were used as positive and negative controls, respectively.

다음으로, 비환원 또는 환원 조건 하에서 4~20% 트리스-글리신 프리캐스트 SDS-PAGE 젤(인비트로젠) 상에서 단백질을 분리하고, 일렉트로블랏팅에 의해 나이트로셀룰로우즈 멤브레인으로 옮겼다. 0.1% 트윈-20을 포함하는 트리스-버퍼드 살린 버퍼(50mM Tris-HCl, pH7.5, 150mM NaCl)에 녹인 5% 넌팻 스킴드 밀크로 비특이적 결합을 블록킹하였다. Next, the proteins were separated on 4-20% Tris-glycine precast SDS-PAGE gel (Invitrogen) under non-reducing or reducing conditions and transferred to nitrocellulose membranes by electroblotting. Nonspecific binding was blocked with 5% non-fat skimmed milk dissolved in Tris-buffered saline buffer (50 mM Tris-HCl, pH7.5, 150 mM NaCl) containing 0.1% Tween-20.

재조합 hGH-Fc 융합단백질을 검출하기 위해, 페록시다아제-표지된 염소 항-인간 면역글로불린(Fc) 항체(1:1000 희석; 바이오신세시스 인코퍼레이티드의 주문 항체)과 페록시다아제-표지된 염소 항-토끼 면역글로불린(H+L) 항체(1:5000 희석; KPL)을 각각 1차와 2차 항체로 사용하였다. hGH-Fc 융합 단백질의 촉매 도메인의 밴드는 원-스텝 NBT/BCIP 서브스트레이트(피어스 케미컬 컴퍼니, 미국 록스포드)로 관찰하였다. 그 결과는 도 5에 나타내었다. 도 5A는 쿠마시-염색된 SDS-PAGE 결과로, M12는 Mark12 wide-range protein markers(인비트로젠)을, YP는 1% 효모 추출물과 2% 펩톤, YPM은 YP+0.5% 메탄올, YPD는 YP+2% 덱스트로우즈, YPF는 YP+0.5% 포름산, YPDF는 YPD+0.5% 포름산, YPH는 YP+0.5% 과산화수소, YPDH는 YPD+0.5% 과산화수소를 의미한다. 도 5B는 과산화수소 유도 배양의 웨스턴 블랏팅 결과를 도시한 것으로, HP는 과산화수소, SeeB는 SeeBlue Plus2 prestained protein makers(인비트로젠)를 의미한다. 화살표는 이량체의 hGH-Fc 융합 단백질의 밴드를 나타낸다.To detect recombinant hGH-Fc fusion protein, peroxidase-labeled goat anti-human immunoglobulin (Fc) antibody (1: 1000 dilution; custom antibody of Biosynthesis Incorporated) and peroxidase- Labeled goat anti-rabbit immunoglobulin (H + L) antibodies (1: 5000 dilution; KPL) were used as primary and secondary antibodies, respectively. Bands of the catalytic domain of the hGH-Fc fusion protein were observed with one-step NBT / BCIP substrates (Pierce Chemical Company, Roxford, USA). The results are shown in FIG. FIG. 5A shows Coomassie-stained SDS-PAGE, M12 shows Mark12 wide-range protein markers (Invitrogen), YP for 1% yeast extract and 2% peptone, YPM for YP + 0.5% methanol, YPD for YP + 2% dextrose, YPF stands for YP + 0.5% formic acid, YPDF stands for YPD + 0.5% formic acid, YPH stands for YP + 0.5% hydrogen peroxide, and YPDH stands for YPD + 0.5% hydrogen peroxide. Figure 5B shows the Western blotting results of hydrogen peroxide induced culture, HP means hydrogen peroxide, SeeB means SeeBlue Plus2 prestained protein makers (Invitrogen). Arrows indicate bands of dimeric hGH-Fc fusion proteins.

도 5A에 나타난 바와 같이, hGH-Fc 융합 단백질은 쿠마시로 염색된 젤 상에서 겨우 검출할 수 있는 수준으로 발현되었다. As shown in FIG. 5A, the hGH-Fc fusion protein was only expressed at detectable levels on Coomassie stained gels.

다음으로, hGH-Fc 융합 단백질의 발현을 유도할 수 있는 과산화수소의 농도를 조사하였다. Next, the concentration of hydrogen peroxide that can induce the expression of the hGH-Fc fusion protein was investigated.

도 5B에 나타난 바와 같이, 0.05~0.5% 농도의 과산화수소가 AOX1 프로모터를 유도하였다. 심지어 과산화수소가 없는 경우에도 AOX1 프로모터는 유도되었다. As shown in FIG. 5B, hydrogen peroxide at a concentration of 0.05-0.5% induced the AOX1 promoter. Even in the absence of hydrogen peroxide, the AOX1 promoter was induced.

다음으로, JW501 균주의 성장에 대한 포름산과 과산화수소의 효과를 농도별로 평가하였다. 스팟 분석을 이용하여, 0.075% 포름산 또는 0.075% 과산화수소를 포함하는 YP 플레이트 상에서 JW501 균주와 X-33 균주의 성장 프로파일을 비교하였다.Next, the effects of formic acid and hydrogen peroxide on the growth of the JW501 strain were evaluated by concentration. Spot analysis was used to compare growth profiles of JW501 strains and X-33 strains on YP plates containing 0.075% formic acid or 0.075% hydrogen peroxide.

도 6A에 나타난 바와 같이, 포름산은 0.075%의 농도에서 JW501 균주를 사멸시켰지만, X-33 숙주 균주에 대해서는 사멸시키지 못했다.As shown in FIG. 6A, formic acid killed the JW501 strain at a concentration of 0.075%, but did not kill for the X-33 host strain.

그러나, 같은 농도에서 과산화수소는 JW501과 X-33 균주 둘 다를 사멸하였다(도 6B).However, at the same concentration, hydrogen peroxide killed both JW501 and X-33 strains (FIG. 6B).

실험예Experimental Example 3:  3: JW501JW501 균주에서  In strain hGHhGH -- FcFc 융합 단백질의 발현 Expression of Fusion Proteins

hGH-Fc 융합 단백질을 분비할 수 있는 JW501 균주의 능력을 평가하였다. 이를 위해, hGH-Fc 융합 단백질을 코딩하는 유전자를 pGAPZα 벡터에 구축하였다. 재조합 유전자는 GAP(glyceraldehyde-3-phosphate dehydrogenase) 프로모터의 조절 하에서 발현하도록 하였고, 유전자 산물 hGH-Fc 융합 단백질의 분비는 알파 메이팅 프리프로 분비 시그널 펩티드(alpha mating prepro secretional signal peptide)에 의해 지시를 받도록 하였다. 그 결과는 도 7에 도시하였다. 도 7A는 쿠마시-염색된 SDS-PAGE 결과를, 도 7B는 웨스턴 블랏팅 결과를 도시한 것이다. 각 번호들은 형질전환체 동정 번호를 나타낸 것이고, 화살표는 이량체 hGH-Fc 융합 단백질의 밴드를 나타낸 것이다. M12는 Mark12 wide-range protein makers(인비트로젠), SeeB는 SeeBlue Plus2 prestained protein makers(인비트로젠)을 의미한다.The ability of the JW501 strain to secrete hGH-Fc fusion protein was evaluated. To this end, a gene encoding the hGH-Fc fusion protein was constructed in the pGAPZα vector. Recombinant genes were expressed under the control of the glyceraldehyde-3-phosphate dehydrogenase (GAP) promoter and secretion of the gene product hGH-Fc fusion protein was directed by an alpha mating prepro secretional signal peptide. It was. The result is shown in FIG. FIG. 7A shows Coomassie-stained SDS-PAGE results and FIG. 7B shows Western blotting results. Each number represents the transformant identification number and the arrow represents the band of the dimeric hGH-Fc fusion protein. M12 stands for Mark12 wide-range protein makers (Invitrogen) and SeeB stands for SeeBlue Plus2 prestained protein makers (Invitrogen).

도 7에 나타난 바와 같이, JW501 균주는 이종 단백질을 발현할 수 있음을 확인하였다.As shown in Figure 7, it was confirmed that the JW501 strain can express a heterologous protein.

도 1은 pPIC3 벡터의 개열지도이다.1 is a cleavage map of a pPIC3 vector.

도 2는 pGAPZα 벡터의 개열지도이다.2 is a cleavage map of the pGAPZα vector.

도 3은 스팟 분석을 이용하여 다양한 성장 배지에서 JW501과 X-33 균주의 성장 프로파일을 비교한 것을 나타낸 것이다. Figure 3 shows a comparison of the growth profile of JW501 and X-33 strain in various growth media using the spot analysis.

도 4는 JW501 균주의 성장 시 옥스갈 추출물의 효과를 나타낸 것이다.Figure 4 shows the effect of oxgal extract on the growth of the JW501 strain.

도 5는 다양한 유도 배지에서 H6 균주에서 얻은 hGH-Fc 융합 단백질의 발현을 나타낸 것으로, A는 쿠마시-염색된 SDS-PAGE, B는 과산화수소 유도 배양의 웨스턴 블랏팅 결과를 나타낸 것이다.Figure 5 shows the expression of hGH-Fc fusion protein obtained in H6 strain in various induction medium, A is Coomassie-stained SDS-PAGE, B is Western blotting results of hydrogen peroxide induction culture.

도 6은 JW501 균주에 대한 포름산의 선택적 사멸 효과를 도시한 것이다.Figure 6 shows the selective killing effect of formic acid on the JW501 strain.

도 7은 JW501 균주에서 hGH-Fc 융합 단백질의 구성적 발현을 도시한 것으로, A는 쿠마시-염색된 SDS-PAGE 결과를, B는 웨스턴 블랏팅 결과를 도시한 것이다.Figure 7 shows the constitutive expression of hGH-Fc fusion protein in JW501 strain, A shows Coomassie-stained SDS-PAGE results, B shows Western blotting results.

<110> INSILICOTECH CO. LTD. <120> A method of intestinal delivery of therapeutic proteins using conditional suicide of genetically modified microorganisms <160> 2 <170> KopatentIn 1.71 <210> 1 <211> 8306 <212> DNA <213> Artificial Sequence <220> <223> vector <400> 1 agatctaaca tccaaagacg aaaggttgaa tgaaaccttt ttgccatccg acatccacag 60 gtccattctc acacataagt gccaaacgca acaggagggg atacactagc agcagaccgt 120 tgcaaacgca ggacctccac tcctcttctc ctcaacaccc acttttgcca tcgaaaaacc 180 agcccagtta ttgggcttga ttggagctcg ctcattccaa ttccttctat taggctacta 240 acaccatgac tttattagcc tgtctatcct ggcccccctg gcgaggttca tgtttgttta 300 tttccgaatg caacaagctc cgcattacac ccgaacatca ctccagatga gggctttctg 360 agtgtggggt caaatagttt catgttcccc aaatggccca aaactgacag tttaaacgct 420 gtcttggaac ctaatatgac aaaagcgtga tctcatccaa gatgaactaa gtttggttcg 480 ttgaaatgct aacggccagt tggtcaaaaa gaaacttcca aaagtcggca taccgtttgt 540 cttgtttggt attgattgac gaatgctcaa aaataatctc attaatgctt agcgcagtct 600 ctctatcgct tctgaacccc ggtgcacctg tgccgaaacg caaatgggga aacacccgct 660 ttttggatga ttatgcattg tctccacatt gtatgcttcc aagattctgg tgggaatact 720 gctgatagcc taacgttcat gatcaaaatt taactgttct aacccctact tgacagcaat 780 atataaacag aaggaagctg ccctgtctta aacctttttt tttatcatca ttattagctt 840 actttcataa ttgcgactgg ttccaattga caagcttttg attttaacga cttttaacga 900 caacttgaga agatcaaaaa acaactaatt attcgaaacg atggctggcg ctgatgatgt 960 cgtcgactcc tccaagtcct tcgtcatgga gaacttcgct tcctaccacg ggaccaagcc 1020 aggttacgtc gactccatcc agaagggtat ccagaagcca aagtccggca cccaaggtaa 1080 ctacgacgac gactggaagg ggttctactc caccgacaac aagtacgacg ctgcgggata 1140 ctctgtagat aatgaaaacc cgctctctgg aaaagctgga ggcgtggtca aagtgacgta 1200 tccaggactg acgaaggttc tcgcactaaa agtggataat gccgaaacta ttaagaaaga 1260 gttaggttta agtctcactg aaccgttgat ggagcaagtc ggaacggaag agtttatcaa 1320 aaggttcggt gatggtgctt cgcgtgtagt gctcagcctt cccttcgctg aggggagttc 1380 tagcgttgaa tatattaata actgggaaca ggcgaaagcg ttaagcgtag aacttgagat 1440 taattttgaa acccgtggaa aacgtggcca agatgcgatg tatgagtata tggctcaagc 1500 ctgagaattc cctagggcgg ccgcgaatta attcgcctta gacatgactg ttcctcagtt 1560 caagttgggc acttacgaga agaccggtct tgctagattc taatcaagag gatgtcagaa 1620 tgccatttgc ctgagagatg caggcttcat ttttgatact tttttatttg taacctatat 1680 agtataggat tttttttgtc attttgtttc ttctcgtacg agcttgctcc tgatcagcct 1740 atctcgcagc tgatgaatat cttgtggtag gggtttggga aaatcattcg agtttgatgt 1800 ttttcttggt atttcccact cctcttcaga gtacagaaga ttaagtgaga agttcgtttg 1860 tgcaagctta tcgataagct ttaatgcggt agtttatcac agttaaattg ctaacgcagt 1920 caggcaccgt gtatgaaatc taacaatgcg ctcatcgtca tcctcggcac cgtcaccctg 1980 gatgctgtag gcataggctt ggttatgccg gtactgccgg gcctcttgcg ggatatcgtc 2040 cattccgaca gcatcgccag tcactatggc gtgctgctag cgctatatgc gttgatgcaa 2100 tttctatgcg cacccgttct cggagcactg tccgaccgct ttggccgccg cccagtcctg 2160 ctcgcttcgc tacttggagc cactatcgac tacgcgatca tggcgaccac acccgtcctg 2220 tggatctatc gaatctaaat gtaagttaaa atctctaaat aattaaataa gtcccagttt 2280 ctccatacga accttaacag cattgcggtg agcatctaga ccttcaacag cagccagatc 2340 catcactgct tggccaatat gtttcagtcc ctcaggagtt acgtcttgtg aagtgatgaa 2400 cttctggaag gttgcagtgt taactccgct gtattgacgg gcatatccgt acgttggcaa 2460 agtgtggttg gtaccggagg agtaatctcc acaactctct ggagagtagg caccaacaaa 2520 cacagatcca gcgtgttgta cttgatcaac ataagaagaa gcattctcga tttgcaggat 2580 caagtgttca ggagcgtact gattggacat ttccaaagcc tgctcgtagg ttgcaaccga 2640 tagggttgta gagtgtgcaa tacacttgcg tacaatttca acccttggca actgcacagc 2700 ttggttgtga acagcatctt caattctggc aagctccttg tctgtcatat cgacagccaa 2760 cagaatcacc tgggaatcaa taccatgttc agcttgagac agaaggtctg aggcaacgaa 2820 atctggatca gcgtatttat cagcaataac tagaacttca gaaggcccag caggcatgtc 2880 aatactacac agggctgatg tgtcattttg aaccatcatc ttggcagcag taacgaactg 2940 gtttcctgga ccaaatattt tgtcacactt aggaacagtt tctgttccgt aagccatagc 3000 agctactgcc tgggcgcctc ctgctagcac gatacactta gcaccaacct tgtgggcaac 3060 gtagatgact tctggggtaa gggtaccatc cttcttaggt ggagatgcaa aaacaatttc 3120 tttgcaacca gcaactttgg caggaacacc cagcatcagg gaagtggaag gcagaattgc 3180 ggttccacca ggaatataga ggccaacttt ctcaataggt cttgcaaaac gagagcagac 3240 tacaccaggg caagtctcaa cttgcaacgt ctccgttagt tgagcttcat ggaatttcct 3300 gacgttatct atagagagat caatggctct cttaacgtta tctggcaatt gcataagttc 3360 ctctgggaaa ggagcttcta acacaggtgt cttcaaagcg actccatcaa acttggcagt 3420 tagttctaaa agggctttgt caccattttg acgaacattg tcgacaattg gtttgactaa 3480 ttccataatc tgttccgttt tctggatagg acgacgaagg gcatcttcaa tttcttgtga 3540 ggaggcctta gaaacgtcaa ttttgcacaa ttcaatacga ccttcagaag ggacttcttt 3600 aggtttggat tcttctttag gttgttcctt ggtgtatcct ggcttggcat ctcctttcct 3660 tctagtgacc tttagggact tcatatccag gtttctctcc acctcgtcca acgtcacacc 3720 gtacttggca catctaacta atgcaaaata aaataagtca gcacattccc aggctatatc 3780 ttccttggat ttagcttctg caagttcatc agcttcctcc ctaattttag cgttcaacaa 3840 aacttcgtcg tcaaataacc gtttggtata agaaccttct ggagcattgc tcttacgatc 3900 ccacaaggtg gcttccatgg ctctaagacc ctttgattgg ccaaaacagg aagtgcgttc 3960 caagtgacag aaaccaacac ctgtttgttc aaccacaaat ttcaagcagt ctccatcaca 4020 atccaattcg atacccagca acttttgagt tgctccagat gtagcacctt tataccacaa 4080 accgtgacga cgagattggt agactccagt ttgtgtcctt atagcctccg gaatagactt 4140 tttggacgag tacaccaggc ccaacgagta attagaagag tcagccacca aagtagtgaa 4200 tagaccatcg gggcggtcag tagtcaaaga cgccaacaaa atttcactga cagggaactt 4260 tttgacatct tcagaaagtt cgtattcagt agtcaattgc cgagcatcaa taatggggat 4320 tataccagaa gcaacagtgg aagtcacatc taccaacttt gcggtctcag aaaaagcata 4380 aacagttcta ctaccgccat tagtgaaact tttcaaatcg cccagtggag aagaaaaagg 4440 cacagcgata ctagcattag cgggcaagga tgcaacttta tcaaccaggg tcctatagat 4500 aaccctagcg cctgggatca tcctttggac aactctttct gccaaatcta ggtccaaaat 4560 cacttcattg ataccattat tgtacaactt gagcaagttg tcgatcagct cctcaaattg 4620 gtcctctgta acggatgact caacttgcac attaacttga agctcagtcg attgagtgaa 4680 cttgatcagg ttgtgcagct ggtcagcagc atagggaaac acggcttttc ctaccaaact 4740 caaggaatta tcaaactctg caacacttgc gtatgcaggt agcaagggaa atgtcatact 4800 tgaagtcgga cagtgagtgt agtcttgaga aattctgaag ccgtattttt attatcagtg 4860 agtcagtcat caggagatcc tctacgccgg acgcatcgtg gccggcatca ccggcgccac 4920 aggtgcggtt gctggcgcct atatcgccga catcaccgat ggggaagatc gggctcgcca 4980 cttcgggctc atgagcgctt gtttcggcgt gggtatggtg gcaggccccg tggccggggg 5040 actgttgggc gccatctcct tgcatgcacc attccttgcg gcggcggtgc tcaacggcct 5100 caacctacta ctgggctgct tcctaatgca ggagtcgcat aagggagagc gtcgagtatc 5160 tatgattgga agtatgggaa tggtgatacc cgcattcttc agtgtcttga ggtctcctat 5220 cagattatgc ccaactaaag caaccggagg aggagatttc atggtaaatt tctctgactt 5280 ttggtcatca gtagactcga actgtgagac tatctcggtt atgacagcag aaatgtcctt 5340 cttggagaca gtaaatgaag tcccaccaat aaagaaatcc ttgttatcag gaacaaactt 5400 cttgtttcga actttttcgg tgccttgaac tataaaatgt agagtggata tgtcgggtag 5460 gaatggagcg ggcaaatgct taccttctgg accttcaaga ggtatgtagg gtttgtagat 5520 actgatgcca acttcagtga caacgttgct atttcgttca aaccattccg aatccagaga 5580 aatcaaagtt gtttgtctac tattgatcca agccagtgcg gtcttgaaac tgacaatagt 5640 gtgctcgtgt tttgaggtca tctttgtatg aataaatcta gtctttgatc taaataatct 5700 tgacgagcca aggcgataaa tacccaaatc taaaactctt ttaaaacgtt aaaaggacaa 5760 gtatgtctgc ctgtattaaa ccccaaatca gctcgtagtc tgatcctcat caacttgagg 5820 ggcactatct tgttttagag aaatttgcgg agatgcgata tcgagaaaaa ggtacgctga 5880 ttttaaacgt gaaatttatc tcaagatctc tgcctcgcgc gtttcggtga tgacggtgaa 5940 aacctctgac acatgcagct cccggagacg gtcacagctt gtctgtaagc ggatgccggg 6000 agcagacaag cccgtcaggg cgcgtcagcg ggtgttggcg ggtgtcgggg cgcagccatg 6060 acccagtcac gtagcgatag cggagtgtat actggcttaa ctatgcggca tcagagcaga 6120 ttgtactgag agtgcaccat atgcggtgtg aaataccgca cagatgcgta aggagaaaat 6180 accgcatcag gcgctcttcc gcttcctcgc tcactgactc gctgcgctcg gtcgttcggc 6240 tgcggcgagc ggtatcagct cactcaaagg cggtaatacg gttatccaca gaatcagggg 6300 ataacgcagg aaagaacatg tgagcaaaag gccagcaaaa ggccaggaac cgtaaaaagg 6360 ccgcgttgct ggcgtttttc cataggctcc gcccccctga cgagcatcac aaaaatcgac 6420 gctcaagtca gaggtggcga aacccgacag gactataaag ataccaggcg tttccccctg 6480 gaagctccct cgtgcgctct cctgttccga ccctgccgct taccggatac ctgtccgcct 6540 ttctcccttc gggaagcgtg gcgctttctc aatgctcacg ctgtaggtat ctcagttcgg 6600 tgtaggtcgt tcgctccaag ctgggctgtg tgcacgaacc ccccgttcag cccgaccgct 6660 gcgccttatc cggtaactat cgtcttgagt ccaacccggt aagacacgac ttatcgccac 6720 tggcagcagc cactggtaac aggattagca gagcgaggta tgtaggcggt gctacagagt 6780 tcttgaagtg gtggcctaac tacggctaca ctagaaggac agtatttggt atctgcgctc 6840 tgctgaagcc agttaccttc ggaaaaagag ttggtagctc ttgatccggc aaacaaacca 6900 ccgctggtag cggtggtttt tttgtttgca agcagcagat tacgcgcaga aaaaaaggat 6960 ctcaagaaga tcctttgatc ttttctacgg ggtctgacgc tcagtggaac gaaaactcac 7020 gttaagggat tttggtcatg agattatcaa aaaggatctt cacctagatc cttttaaatt 7080 aaaaatgaag ttttaaatca atctaaagta tatatgagta aacttggtct gacagttacc 7140 aatgcttaat cagtgaggca cctatctcag cgatctgtct atttcgttca tccatagttg 7200 cctgactccc cgtcgtgtag ataactacga tacgggaggg cttaccatct ggccccagtg 7260 ctgcaatgat accgcgagac ccacgctcac cggctccaga tttatcagca ataaaccagc 7320 cagccggaag ggccgagcgc agaagtggtc ctgcaacttt atccgcctcc atccagtcta 7380 ttaattgttg ccgggaagct agagtaagta gttcgccagt taatagtttg cgcaacgttg 7440 ttgccattgc tgcaggcatc gtggtgtcac gctcgtcgtt tggtatggct tcattcagct 7500 ccggttccca acgatcaagg cgagttacat gatcccccat gttgtgcaaa aaagcggtta 7560 gctccttcgg tcctccgatc gttgtcagaa gtaagttggc cgcagtgtta tcactcatgg 7620 ttatggcagc actgcataat tctcttactg tcatgccatc cgtaagatgc ttttctgtga 7680 ctggtgagta ctcaaccaag tcattctgag aatagtgtat gcggcgaccg agttgctctt 7740 gcccggcgtc aacacgggat aataccgcgc cacatagcag aactttaaaa gtgctcatca 7800 ttggaaaacg ttcttcgggg cgaaaactct caaggatctt accgctgttg agatccagtt 7860 cgatgtaacc cactcgtgca cccaactgat cttcagcatc ttttactttc accagcgttt 7920 ctgggtgagc aaaaacagga aggcaaaatg ccgcaaaaaa gggaataagg gcgacacgga 7980 aatgttgaat actcatactc ttcctttttc aatattattg aagcatttat cagggttatt 8040 gtctcatgag cggatacata tttgaatgta tttagaaaaa taaacaaata ggggttccgc 8100 gcacatttcc ccgaaaagtg ccacctgacg tctaagaaac cattattatc atgacattaa 8160 cctataaaaa taggcgtatc acgaggccct ttcgtcttca agaattaatt ctcatgtttg 8220 acagcttatc atcgataagc tgactcatgt tggtattgtg aaatagacgc agatcgggaa 8280 cactgaaaaa taacagttat tattcg 8306 <210> 2 <211> 4443 <212> DNA <213> Artificial Sequence <220> <223> vector <400> 2 agatcttttt tgtagaaatg tcttggtgtc ctcgtccaat caggtagcca tctctgaaat 60 atctggctcc gttgcaactc cgaacgacct gctggcaacg taaaattctc cggggtaaaa 120 cttaaatgtg gagtaatgga accagaaacg tctcttccct tctctctcct tccaccgccc 180 gttaccgtcc ctaggaaatt ttactctgct ggagagcttc ttctacggcc cccttgcagc 240 aatgctcttc ccagcattac gttgcgggta aaacggaggt cgtgtacccg acctagcagc 300 ccagggatgg aaaagtcccg gccgtcgctg gcaataatag cgggcggacg catgtcatga 360 gattattgga aaccaccaga atcgaatata aaaggcgaac acctttccca attttggttt 420 ctcctgaccc aaagacttta aatttaattt atttgtccct atttcaatca attgaacaac 480 tatttcgaaa cgatgagatt tccttcaatt tttactgctg ttttattcgc agcatcctcc 540 gcattagctg ctccagtcaa cactacaaca gaagatgaaa cggcacaaat tccggctgaa 600 gctgtcatcg gttactcaga tttagaaggg gatttcgatg ttgctgtttt gccattttcc 660 aacagcacaa ataacgggtt attgtttata aatactacta ttgccagcat tgctgctaaa 720 gaagaagggg tatctctcga gaaaagagcc ttcccaacca ttcccttatc cagattgttc 780 gacaacgcta tgttgagagc ccacagactg caccagctgg cctttgacac ctaccaggag 840 tttgaagaag cctatatccc aaaggaacag aagtattcat tcctgcagaa cccccagacc 900 tccctctgtt tctcagagtc tattccgaca ccctccaaca gggaggaaac acaacagaaa 960 tccaacctag agctgctccg catctccctg ctgctcatcc agtcgtggct ggagcccgtg 1020 cagttcctca ggagtgtctt cgccaacagc ctggtgtacg gcgcctctga cagcaacgtc 1080 tatgacctcc taaaggacct agaggaaggc atccaaacgc tgatggggag gctggaagat 1140 ggcagccccc ggactgggca gatcttcaag cagacctaca gcaagttcga cacaaactca 1200 cacaacgatg acgcactact caagaactac gggctgctct actgcttcag gaaggacatg 1260 gacaaggtcg agacattcct gcgcatcgtg cagtgccgct ctgtggaggg cagctgtggc 1320 ttcggtggag gtggatccga gcccaaatct tgtgacaaaa ctcacacatg cccaccgtgc 1380 ccagcacctg aactcctggg gggaccgtca gtcttcctct tccccccaaa acccaaggac 1440 accctcatga tctcccggac ccctgaggtc acatgcgtgg tggtggacgt gagccacgaa 1500 gaccctgagg tcaagttcaa ctggtacgtg gacggcgtgg aggtgcataa tgccaagaca 1560 aagccgcggg aggagcagta caacagcacg taccgggtgg tcagcgtcct caccgtcctg 1620 caccaggact ggctgaatgg caaggagtac aagtgcaagg tctccaacaa agccctccca 1680 gcccccatcg agaaaaccat ctccaaagcc aaagggcagc cccgagaacc acaggtgtac 1740 accctgcccc catcccggga tgagctgacc aagaaccagg tcagcctgac ctgcctggtc 1800 aaaggcttct atcccagcga catcgccgtg gagtgggaga gcaatgggca gccggagaac 1860 aactacaaga ccacgcctcc cgtgctggac tccgacggct ccttcttcct ctacagcaag 1920 ctcaccgtgg acaagagcag gtggcagcag gggaacgtct tctcatgctc cgtgatgcat 1980 gaggctctgc acaaccacta cacgcagaag agcctctccc tgtctccggg taaacaccac 2040 caccaccacc actgagaatt cacgtggccc agccggccgt ctcggatcgg tacctcgagc 2100 cgcggcggcc gccagctttc tagaacaaaa actcatctca gaagaggatc tgaatagcgc 2160 cgtcgaccat catcatcatc atcattgagt tttagcctta gacatgactg ttcctcagtt 2220 caagttgggc acttacgaga agaccggtct tgctagattc taatcaagag gatgtcagaa 2280 tgccatttgc ctgagagatg caggcttcat ttttgatact tttttatttg taacctatat 2340 agtataggat tttttttgtc attttgtttc ttctcgtacg agcttgctcc tgatcagcct 2400 atctcgcagc tgatgaatat cttgtggtag gggtttggga aaatcattcg agtttgatgt 2460 ttttcttggt atttcccact cctcttcaga gtacagaaga ttaagtgaga ccttcgtttg 2520 tgcggatccc ccacacacca tagcttcaaa atgtttctac tcctttttta ctcttccaga 2580 ttttctcgga ctccgcgcat cgccgtacca cttcaaaaca cccaagcaca gcatactaaa 2640 ttttccctct ttcttcctct agggtgtcgt taattacccg tactaaaggt ttggaaaaga 2700 aaaaagagac cgcctcgttt ctttttcttc gtcgaaaaag gcaataaaaa tttttatcac 2760 gtttcttttt cttgaaattt ttttttttag tttttttctc tttcagtgac ctccattgat 2820 atttaagtta ataaacggtc ttcaatttct caagtttcag tttcattttt cttgttctat 2880 tacaactttt tttacttctt gttcattaga aagaaagcat agcaatctaa tctaagggcg 2940 gtgttgacaa ttaatcatcg gcatagtata tcggcatagt ataatacgac aaggtgagga 3000 actaaaccat ggccaagttg accagtgccg ttccggtgct caccgcgcgc gacgtcgccg 3060 gagcggtcga gttctggacc gaccggctcg ggttctcccg ggacttcgtg gaggacgact 3120 tcgccggtgt ggtccgggac gacgtgaccc tgttcatcag cgcggtccag gaccaggtgg 3180 tgccggacaa caccctggcc tgggtgtggg tgcgcggcct ggacgagctg tacgccgagt 3240 ggtcggaggt cgtgtccacg aacttccggg acgcctccgg gccggccatg accgagatcg 3300 gcgagcagcc gtgggggcgg gagttcgccc tgcgcgaccc ggccggcaac tgcgtgcact 3360 tcgtggccga ggagcaggac tgacacgtcc gacggcggcc cacgggtccc aggcctcgga 3420 gatccgtccc ccttttcctt tgtcgatatc atgtaattag ttatgtcacg cttacattca 3480 cgccctcccc ccacatccgc tctaaccgaa aaggaaggag ttagacaacc tgaagtctag 3540 gtccctattt atttttttat agttatgtta gtattaagaa cgttatttat atttcaaatt 3600 tttctttttt ttctgtacag acgcgtgtac gcatgtaaca ttatactgaa aaccttgctt 3660 gagaaggttt tgggacgctc gaaggcttta atttgcaagc tggagaccaa catgtgagca 3720 aaaggccagc aaaaggccag gaaccgtaaa aaggccgcgt tgctggcgtt tttccatagg 3780 ctccgccccc ctgacgagca tcacaaaaat cgacgctcaa gtcagaggtg gcgaaacccg 3840 acaggactat aaagatacca ggcgtttccc cctggaagct ccctcgtgcg ctctcctgtt 3900 ccgaccctgc cgcttaccgg atacctgtcc gcctttctcc cttcgggaag cgtggcgctt 3960 tctcaatgct cacgctgtag gtatctcagt tcggtgtagg tcgttcgctc caagctgggc 4020 tgtgtgcacg aaccccccgt tcagcccgac cgctgcgcct tatccggtaa ctatcgtctt 4080 gagtccaacc cggtaagaca cgacttatcg ccactggcag cagccactgg taacaggatt 4140 agcagagcga ggtatgtagg cggtgctaca gagttcttga agtggtggcc taactacggc 4200 tacactagaa ggacagtatt tggtatctgc gctctgctga agccagttac cttcggaaaa 4260 agagttggta gctcttgatc cggcaaacaa accaccgctg gtagcggtgg tttttttgtt 4320 tgcaagcagc agattacgcg cagaaaaaaa ggatctcaag aagatccttt gatcttttct 4380 acggggtctg acgctcagtg gaacgaaaac tcacgttaag ggattttggt catgcatgag 4440 atc 4443 <110> INSILICOTECH CO. LTD. <120> A method of intestinal delivery of therapeutic proteins using          conditional suicide of genetically modified microorganisms <160> 2 <170> KopatentIn 1.71 <210> 1 <211> 8306 <212> DNA <213> Artificial Sequence <220> <223> vector <400> 1 agatctaaca tccaaagacg aaaggttgaa tgaaaccttt ttgccatccg acatccacag 60 gtccattctc acacataagt gccaaacgca acaggagggg atacactagc agcagaccgt 120 tgcaaacgca ggacctccac tcctcttctc ctcaacaccc acttttgcca tcgaaaaacc 180 agcccagtta ttgggcttga ttggagctcg ctcattccaa ttccttctat taggctacta 240 acaccatgac tttattagcc tgtctatcct ggcccccctg gcgaggttca tgtttgttta 300 tttccgaatg caacaagctc cgcattacac ccgaacatca ctccagatga gggctttctg 360 agtgtggggt caaatagttt catgttcccc aaatggccca aaactgacag tttaaacgct 420 gtcttggaac ctaatatgac aaaagcgtga tctcatccaa gatgaactaa gtttggttcg 480 ttgaaatgct aacggccagt tggtcaaaaa gaaacttcca aaagtcggca taccgtttgt 540 cttgtttggt attgattgac gaatgctcaa aaataatctc attaatgctt agcgcagtct 600 ctctatcgct tctgaacccc ggtgcacctg tgccgaaacg caaatgggga aacacccgct 660 ttttggatga ttatgcattg tctccacatt gtatgcttcc aagattctgg tgggaatact 720 gctgatagcc taacgttcat gatcaaaatt taactgttct aacccctact tgacagcaat 780 atataaacag aaggaagctg ccctgtctta aacctttttt tttatcatca ttattagctt 840 actttcataa ttgcgactgg ttccaattga caagcttttg attttaacga cttttaacga 900 caacttgaga agatcaaaaa acaactaatt attcgaaacg atggctggcg ctgatgatgt 960 cgtcgactcc tccaagtcct tcgtcatgga gaacttcgct tcctaccacg ggaccaagcc 1020 aggttacgtc gactccatcc agaagggtat ccagaagcca aagtccggca cccaaggtaa 1080 ctacgacgac gactggaagg ggttctactc caccgacaac aagtacgacg ctgcgggata 1140 ctctgtagat aatgaaaacc cgctctctgg aaaagctgga ggcgtggtca aagtgacgta 1200 tccaggactg acgaaggttc tcgcactaaa agtggataat gccgaaacta ttaagaaaga 1260 gttaggttta agtctcactg aaccgttgat ggagcaagtc ggaacggaag agtttatcaa 1320 aaggttcggt gatggtgctt cgcgtgtagt gctcagcctt cccttcgctg aggggagttc 1380 tagcgttgaa tatattaata actgggaaca ggcgaaagcg ttaagcgtag aacttgagat 1440 taattttgaa acccgtggaa aacgtggcca agatgcgatg tatgagtata tggctcaagc 1500 ctgagaattc cctagggcgg ccgcgaatta attcgcctta gacatgactg ttcctcagtt 1560 caagttgggc acttacgaga agaccggtct tgctagattc taatcaagag gatgtcagaa 1620 tgccatttgc ctgagagatg caggcttcat ttttgatact tttttatttg taacctatat 1680 agtataggat tttttttgtc attttgtttc ttctcgtacg agcttgctcc tgatcagcct 1740 atctcgcagc tgatgaatat cttgtggtag gggtttggga aaatcattcg agtttgatgt 1800 ttttcttggt atttcccact cctcttcaga gtacagaaga ttaagtgaga agttcgtttg 1860 tgcaagctta tcgataagct ttaatgcggt agtttatcac agttaaattg ctaacgcagt 1920 caggcaccgt gtatgaaatc taacaatgcg ctcatcgtca tcctcggcac cgtcaccctg 1980 gatgctgtag gcataggctt ggttatgccg gtactgccgg gcctcttgcg ggatatcgtc 2040 cattccgaca gcatcgccag tcactatggc gtgctgctag cgctatatgc gttgatgcaa 2100 tttctatgcg cacccgttct cggagcactg tccgaccgct ttggccgccg cccagtcctg 2160 ctcgcttcgc tacttggagc cactatcgac tacgcgatca tggcgaccac acccgtcctg 2220 tggatctatc gaatctaaat gtaagttaaa atctctaaat aattaaataa gtcccagttt 2280 ctccatacga accttaacag cattgcggtg agcatctaga ccttcaacag cagccagatc 2340 catcactgct tggccaatat gtttcagtcc ctcaggagtt acgtcttgtg aagtgatgaa 2400 cttctggaag gttgcagtgt taactccgct gtattgacgg gcatatccgt acgttggcaa 2460 agtgtggttg gtaccggagg agtaatctcc acaactctct ggagagtagg caccaacaaa 2520 cacagatcca gcgtgttgta cttgatcaac ataagaagaa gcattctcga tttgcaggat 2580 caagtgttca ggagcgtact gattggacat ttccaaagcc tgctcgtagg ttgcaaccga 2640 tagggttgta gagtgtgcaa tacacttgcg tacaatttca acccttggca actgcacagc 2700 ttggttgtga acagcatctt caattctggc aagctccttg tctgtcatat cgacagccaa 2760 cagaatcacc tgggaatcaa taccatgttc agcttgagac agaaggtctg aggcaacgaa 2820 atctggatca gcgtatttat cagcaataac tagaacttca gaaggcccag caggcatgtc 2880 aatactacac agggctgatg tgtcattttg aaccatcatc ttggcagcag taacgaactg 2940 gtttcctgga ccaaatattt tgtcacactt aggaacagtt tctgttccgt aagccatagc 3000 agctactgcc tgggcgcctc ctgctagcac gatacactta gcaccaacct tgtgggcaac 3060 gtagatgact tctggggtaa gggtaccatc cttcttaggt ggagatgcaa aaacaatttc 3120 tttgcaacca gcaactttgg caggaacacc cagcatcagg gaagtggaag gcagaattgc 3180 ggttccacca ggaatataga ggccaacttt ctcaataggt cttgcaaaac gagagcagac 3240 tacaccaggg caagtctcaa cttgcaacgt ctccgttagt tgagcttcat ggaatttcct 3300 gacgttatct atagagagat caatggctct cttaacgtta tctggcaatt gcataagttc 3360 ctctgggaaa ggagcttcta acacaggtgt cttcaaagcg actccatcaa acttggcagt 3420 tagttctaaa agggctttgt caccattttg acgaacattg tcgacaattg gtttgactaa 3480 ttccataatc tgttccgttt tctggatagg acgacgaagg gcatcttcaa tttcttgtga 3540 ggaggcctta gaaacgtcaa ttttgcacaa ttcaatacga ccttcagaag ggacttcttt 3600 aggtttggat tcttctttag gttgttcctt ggtgtatcct ggcttggcat ctcctttcct 3660 tctagtgacc tttagggact tcatatccag gtttctctcc acctcgtcca acgtcacacc 3720 gtacttggca catctaacta atgcaaaata aaataagtca gcacattccc aggctatatc 3780 ttccttggat ttagcttctg caagttcatc agcttcctcc ctaattttag cgttcaacaa 3840 aacttcgtcg tcaaataacc gtttggtata agaaccttct ggagcattgc tcttacgatc 3900 ccacaaggtg gcttccatgg ctctaagacc ctttgattgg ccaaaacagg aagtgcgttc 3960 caagtgacag aaaccaacac ctgtttgttc aaccacaaat ttcaagcagt ctccatcaca 4020 atccaattcg atacccagca acttttgagt tgctccagat gtagcacctt tataccacaa 4080 accgtgacga cgagattggt agactccagt ttgtgtcctt atagcctccg gaatagactt 4140 tttggacgag tacaccaggc ccaacgagta attagaagag tcagccacca aagtagtgaa 4200 tagaccatcg gggcggtcag tagtcaaaga cgccaacaaa atttcactga cagggaactt 4260 tttgacatct tcagaaagtt cgtattcagt agtcaattgc cgagcatcaa taatggggat 4320 tataccagaa gcaacagtgg aagtcacatc taccaacttt gcggtctcag aaaaagcata 4380 aacagttcta ctaccgccat tagtgaaact tttcaaatcg cccagtggag aagaaaaagg 4440 cacagcgata ctagcattag cgggcaagga tgcaacttta tcaaccaggg tcctatagat 4500 aaccctagcg cctgggatca tcctttggac aactctttct gccaaatcta ggtccaaaat 4560 cacttcattg ataccattat tgtacaactt gagcaagttg tcgatcagct cctcaaattg 4620 gtcctctgta acggatgact caacttgcac attaacttga agctcagtcg attgagtgaa 4680 cttgatcagg ttgtgcagct ggtcagcagc atagggaaac acggcttttc ctaccaaact 4740 caaggaatta tcaaactctg caacacttgc gtatgcaggt agcaagggaa atgtcatact 4800 tgaagtcgga cagtgagtgt agtcttgaga aattctgaag ccgtattttt attatcagtg 4860 agtcagtcat caggagatcc tctacgccgg acgcatcgtg gccggcatca ccggcgccac 4920 aggtgcggtt gctggcgcct atatcgccga catcaccgat ggggaagatc gggctcgcca 4980 cttcgggctc atgagcgctt gtttcggcgt gggtatggtg gcaggccccg tggccggggg 5040 actgttgggc gccatctcct tgcatgcacc attccttgcg gcggcggtgc tcaacggcct 5100 caacctacta ctgggctgct tcctaatgca ggagtcgcat aagggagagc gtcgagtatc 5160 tatgattgga agtatgggaa tggtgatacc cgcattcttc agtgtcttga ggtctcctat 5220 cagattatgc ccaactaaag caaccggagg aggagatttc atggtaaatt tctctgactt 5280 ttggtcatca gtagactcga actgtgagac tatctcggtt atgacagcag aaatgtcctt 5340 cttggagaca gtaaatgaag tcccaccaat aaagaaatcc ttgttatcag gaacaaactt 5400 cttgtttcga actttttcgg tgccttgaac tataaaatgt agagtggata tgtcgggtag 5460 gaatggagcg ggcaaatgct taccttctgg accttcaaga ggtatgtagg gtttgtagat 5520 actgatgcca acttcagtga caacgttgct atttcgttca aaccattccg aatccagaga 5580 aatcaaagtt gtttgtctac tattgatcca agccagtgcg gtcttgaaac tgacaatagt 5640 gtgctcgtgt tttgaggtca tctttgtatg aataaatcta gtctttgatc taaataatct 5700 tgacgagcca aggcgataaa tacccaaatc taaaactctt ttaaaacgtt aaaaggacaa 5760 gtatgtctgc ctgtattaaa ccccaaatca gctcgtagtc tgatcctcat caacttgagg 5820 ggcactatct tgttttagag aaatttgcgg agatgcgata tcgagaaaaa ggtacgctga 5880 ttttaaacgt gaaatttatc tcaagatctc tgcctcgcgc gtttcggtga tgacggtgaa 5940 aacctctgac acatgcagct cccggagacg gtcacagctt gtctgtaagc ggatgccggg 6000 agcagacaag cccgtcaggg cgcgtcagcg ggtgttggcg ggtgtcgggg cgcagccatg 6060 acccagtcac gtagcgatag cggagtgtat actggcttaa ctatgcggca tcagagcaga 6120 ttgtactgag agtgcaccat atgcggtgtg aaataccgca cagatgcgta aggagaaaat 6180 accgcatcag gcgctcttcc gcttcctcgc tcactgactc gctgcgctcg gtcgttcggc 6240 tgcggcgagc ggtatcagct cactcaaagg cggtaatacg gttatccaca gaatcagggg 6300 ataacgcagg aaagaacatg tgagcaaaag gccagcaaaa ggccaggaac cgtaaaaagg 6360 ccgcgttgct ggcgtttttc cataggctcc gcccccctga cgagcatcac aaaaatcgac 6420 gctcaagtca gaggtggcga aacccgacag gactataaag ataccaggcg tttccccctg 6480 gaagctccct cgtgcgctct cctgttccga ccctgccgct taccggatac ctgtccgcct 6540 ttctcccttc gggaagcgtg gcgctttctc aatgctcacg ctgtaggtat ctcagttcgg 6600 tgtaggtcgt tcgctccaag ctgggctgtg tgcacgaacc ccccgttcag cccgaccgct 6660 gcgccttatc cggtaactat cgtcttgagt ccaacccggt aagacacgac ttatcgccac 6720 tggcagcagc cactggtaac aggattagca gagcgaggta tgtaggcggt gctacagagt 6780 tcttgaagtg gtggcctaac tacggctaca ctagaaggac agtatttggt atctgcgctc 6840 tgctgaagcc agttaccttc ggaaaaagag ttggtagctc ttgatccggc aaacaaacca 6900 ccgctggtag cggtggtttt tttgtttgca agcagcagat tacgcgcaga aaaaaaggat 6960 ctcaagaaga tcctttgatc ttttctacgg ggtctgacgc tcagtggaac gaaaactcac 7020 gttaagggat tttggtcatg agattatcaa aaaggatctt cacctagatc cttttaaatt 7080 aaaaatgaag ttttaaatca atctaaagta tatatgagta aacttggtct gacagttacc 7140 aatgcttaat cagtgaggca cctatctcag cgatctgtct atttcgttca tccatagttg 7200 cctgactccc cgtcgtgtag ataactacga tacgggaggg cttaccatct ggccccagtg 7260 ctgcaatgat accgcgagac ccacgctcac cggctccaga tttatcagca ataaaccagc 7320 cagccggaag ggccgagcgc agaagtggtc ctgcaacttt atccgcctcc atccagtcta 7380 ttaattgttg ccgggaagct agagtaagta gttcgccagt taatagtttg cgcaacgttg 7440 ttgccattgc tgcaggcatc gtggtgtcac gctcgtcgtt tggtatggct tcattcagct 7500 ccggttccca acgatcaagg cgagttacat gatcccccat gttgtgcaaa aaagcggtta 7560 gctccttcgg tcctccgatc gttgtcagaa gtaagttggc cgcagtgtta tcactcatgg 7620 ttatggcagc actgcataat tctcttactg tcatgccatc cgtaagatgc ttttctgtga 7680 ctggtgagta ctcaaccaag tcattctgag aatagtgtat gcggcgaccg agttgctctt 7740 gcccggcgtc aacacgggat aataccgcgc cacatagcag aactttaaaa gtgctcatca 7800 ttggaaaacg ttcttcgggg cgaaaactct caaggatctt accgctgttg agatccagtt 7860 cgatgtaacc cactcgtgca cccaactgat cttcagcatc ttttactttc accagcgttt 7920 ctgggtgagc aaaaacagga aggcaaaatg ccgcaaaaaa gggaataagg gcgacacgga 7980 aatgttgaat actcatactc ttcctttttc aatattattg aagcatttat cagggttatt 8040 gtctcatgag cggatacata tttgaatgta tttagaaaaa taaacaaata ggggttccgc 8100 gcacatttcc ccgaaaagtg ccacctgacg tctaagaaac cattattatc atgacattaa 8160 cctataaaaa taggcgtatc acgaggccct ttcgtcttca agaattaatt ctcatgtttg 8220 acagcttatc atcgataagc tgactcatgt tggtattgtg aaatagacgc agatcgggaa 8280 cactgaaaaa taacagttat tattcg 8306 <210> 2 <211> 4443 <212> DNA <213> Artificial Sequence <220> <223> vector <400> 2 agatcttttt tgtagaaatg tcttggtgtc ctcgtccaat caggtagcca tctctgaaat 60 atctggctcc gttgcaactc cgaacgacct gctggcaacg taaaattctc cggggtaaaa 120 cttaaatgtg gagtaatgga accagaaacg tctcttccct tctctctcct tccaccgccc 180 gttaccgtcc ctaggaaatt ttactctgct ggagagcttc ttctacggcc cccttgcagc 240 aatgctcttc ccagcattac gttgcgggta aaacggaggt cgtgtacccg acctagcagc 300 ccagggatgg aaaagtcccg gccgtcgctg gcaataatag cgggcggacg catgtcatga 360 gattattgga aaccaccaga atcgaatata aaaggcgaac acctttccca attttggttt 420 ctcctgaccc aaagacttta aatttaattt atttgtccct atttcaatca attgaacaac 480 tatttcgaaa cgatgagatt tccttcaatt tttactgctg ttttattcgc agcatcctcc 540 gcattagctg ctccagtcaa cactacaaca gaagatgaaa cggcacaaat tccggctgaa 600 gctgtcatcg gttactcaga tttagaaggg gatttcgatg ttgctgtttt gccattttcc 660 aacagcacaa ataacgggtt attgtttata aatactacta ttgccagcat tgctgctaaa 720 gaagaagggg tatctctcga gaaaagagcc ttcccaacca ttcccttatc cagattgttc 780 gacaacgcta tgttgagagc ccacagactg caccagctgg cctttgacac ctaccaggag 840 tttgaagaag cctatatccc aaaggaacag aagtattcat tcctgcagaa cccccagacc 900 tccctctgtt tctcagagtc tattccgaca ccctccaaca gggaggaaac acaacagaaa 960 tccaacctag agctgctccg catctccctg ctgctcatcc agtcgtggct ggagcccgtg 1020 cagttcctca ggagtgtctt cgccaacagc ctggtgtacg gcgcctctga cagcaacgtc 1080 tatgacctcc taaaggacct agaggaaggc atccaaacgc tgatggggag gctggaagat 1140 ggcagccccc ggactgggca gatcttcaag cagacctaca gcaagttcga cacaaactca 1200 cacaacgatg acgcactact caagaactac gggctgctct actgcttcag gaaggacatg 1260 gacaaggtcg agacattcct gcgcatcgtg cagtgccgct ctgtggaggg cagctgtggc 1320 ttcggtggag gtggatccga gcccaaatct tgtgacaaaa ctcacacatg cccaccgtgc 1380 ccagcacctg aactcctggg gggaccgtca gtcttcctct tccccccaaa acccaaggac 1440 accctcatga tctcccggac ccctgaggtc acatgcgtgg tggtggacgt gagccacgaa 1500 gaccctgagg tcaagttcaa ctggtacgtg gacggcgtgg aggtgcataa tgccaagaca 1560 aagccgcggg aggagcagta caacagcacg taccgggtgg tcagcgtcct caccgtcctg 1620 caccaggact ggctgaatgg caaggagtac aagtgcaagg tctccaacaa agccctccca 1680 gcccccatcg agaaaaccat ctccaaagcc aaagggcagc cccgagaacc acaggtgtac 1740 accctgcccc catcccggga tgagctgacc aagaaccagg tcagcctgac ctgcctggtc 1800 aaaggcttct atcccagcga catcgccgtg gagtgggaga gcaatgggca gccggagaac 1860 aactacaaga ccacgcctcc cgtgctggac tccgacggct ccttcttcct ctacagcaag 1920 ctcaccgtgg acaagagcag gtggcagcag gggaacgtct tctcatgctc cgtgatgcat 1980 gaggctctgc acaaccacta cacgcagaag agcctctccc tgtctccggg taaacaccac 2040 caccaccacc actgagaatt cacgtggccc agccggccgt ctcggatcgg tacctcgagc 2100 cgcggcggcc gccagctttc tagaacaaaa actcatctca gaagaggatc tgaatagcgc 2160 cgtcgaccat catcatcatc atcattgagt tttagcctta gacatgactg ttcctcagtt 2220 caagttgggc acttacgaga agaccggtct tgctagattc taatcaagag gatgtcagaa 2280 tgccatttgc ctgagagatg caggcttcat ttttgatact tttttatttg taacctatat 2340 agtataggat tttttttgtc attttgtttc ttctcgtacg agcttgctcc tgatcagcct 2400 atctcgcagc tgatgaatat cttgtggtag gggtttggga aaatcattcg agtttgatgt 2460 ttttcttggt atttcccact cctcttcaga gtacagaaga ttaagtgaga ccttcgtttg 2520 tgcggatccc ccacacacca tagcttcaaa atgtttctac tcctttttta ctcttccaga 2580 ttttctcgga ctccgcgcat cgccgtacca cttcaaaaca cccaagcaca gcatactaaa 2640 ttttccctct ttcttcctct agggtgtcgt taattacccg tactaaaggt ttggaaaaga 2700 aaaaagagac cgcctcgttt ctttttcttc gtcgaaaaag gcaataaaaa tttttatcac 2760 gtttcttttt cttgaaattt ttttttttag tttttttctc tttcagtgac ctccattgat 2820 atttaagtta ataaacggtc ttcaatttct caagtttcag tttcattttt cttgttctat 2880 tacaactttt tttacttctt gttcattaga aagaaagcat agcaatctaa tctaagggcg 2940 gtgttgacaa ttaatcatcg gcatagtata tcggcatagt ataatacgac aaggtgagga 3000 actaaaccat ggccaagttg accagtgccg ttccggtgct caccgcgcgc gacgtcgccg 3060 gagcggtcga gttctggacc gaccggctcg ggttctcccg ggacttcgtg gaggacgact 3120 tcgccggtgt ggtccgggac gacgtgaccc tgttcatcag cgcggtccag gaccaggtgg 3180 tgccggacaa caccctggcc tgggtgtggg tgcgcggcct ggacgagctg tacgccgagt 3240 ggtcggaggt cgtgtccacg aacttccggg acgcctccgg gccggccatg accgagatcg 3300 gcgagcagcc gtgggggcgg gagttcgccc tgcgcgaccc ggccggcaac tgcgtgcact 3360 tcgtggccga ggagcaggac tgacacgtcc gacggcggcc cacgggtccc aggcctcgga 3420 gatccgtccc ccttttcctt tgtcgatatc atgtaattag ttatgtcacg cttacattca 3480 cgccctcccc ccacatccgc tctaaccgaa aaggaaggag ttagacaacc tgaagtctag 3540 gtccctattt atttttttat agttatgtta gtattaagaa cgttatttat atttcaaatt 3600 tttctttttt ttctgtacag acgcgtgtac gcatgtaaca ttatactgaa aaccttgctt 3660 gagaaggttt tgggacgctc gaaggcttta atttgcaagc tggagaccaa catgtgagca 3720 aaaggccagc aaaaggccag gaaccgtaaa aaggccgcgt tgctggcgtt tttccatagg 3780 ctccgccccc ctgacgagca tcacaaaaat cgacgctcaa gtcagaggtg gcgaaacccg 3840 acaggactat aaagatacca ggcgtttccc cctggaagct ccctcgtgcg ctctcctgtt 3900 ccgaccctgc cgcttaccgg atacctgtcc gcctttctcc cttcgggaag cgtggcgctt 3960 tctcaatgct cacgctgtag gtatctcagt tcggtgtagg tcgttcgctc caagctgggc 4020 tgtgtgcacg aaccccccgt tcagcccgac cgctgcgcct tatccggtaa ctatcgtctt 4080 gagtccaacc cggtaagaca cgacttatcg ccactggcag cagccactgg taacaggatt 4140 agcagagcga ggtatgtagg cggtgctaca gagttcttga agtggtggcc taactacggc 4200 tacactagaa ggacagtatt tggtatctgc gctctgctga agccagttac cttcggaaaa 4260 agagttggta gctcttgatc cggcaaacaa accaccgctg gtagcggtgg tttttttgtt 4320 tgcaagcagc agattacgcg cagaaaaaaa ggatctcaag aagatccttt gatcttttct 4380 acggggtctg acgctcagtg gaacgaaaac tcacgttaag ggattttggt catgcatgag 4440 atc 4443  

Claims (5)

디프테리아 독소의 촉매 도메인 1~185 아미노산 잔기를 코딩하는 유전자를 야생형 피치아 파스토리스(Pichia pastoris) 균주에 도입하여 AOX1 프로모터의 조절 하에서 조건적으로 자살하는 피치아 파스토리스(Pichia pastoris) 형질전환체의 제조방법.The gene encoding the catalytic domain 1-185 amino acid residues of diphtheria toxin was expressed in wild type Pichia. pastoris ) Pichia under the conditional suicide under the control of the AOX1 promoter pastoris ) A method for producing a transformant. 제1항에 있어서, 상기 형질전환체는 인간의 성장 호르몬과 인간의 면역글로불린 1의 Fc 영역으로 구성된 융합 단백질의 코딩유전자, GAP 프로모터 및 알파 메이팅 프리프로 분비 시그널 펩티드(alpha mating prepro secretional signal peptide)를 추가로 포함함을 특징으로 하는 피치아 파스토리스(Pichia pastoris) 형질전환체의 제조방법.The method of claim 1, wherein the transformant is a coding gene, a GAP promoter and an alpha mating prepro secretional signal peptide of a fusion protein composed of human growth hormone and human immunoglobulin 1 Fc region. Method for producing a Pichia pastoris transformant, characterized in that it further comprises. 제1항 또는 제2항에 있어서, 상기 형질전환체의 조건적 자살은 탄소원으로 메탄올 또는 글루코오스을 사용하고 0.075%의 포름산에 의해 유도되는 AOX1(알코올 옥시다아제 1) 프로모터의 조절 조건에 일어남을 특징으로 하는 피치아 파스토리스(Pichia pastoris) 형질전환체의 제조방법.The method of claim 1 or 2, wherein the conditional suicide of the transformant is characterized by the condition of regulation of the AOX1 (alcohol oxidase 1) promoter induced by 0.075% formic acid using methanol or glucose as a carbon source. Pichia Pastoris pastoris ) A method for producing a transformant. 제1항 또는 제2항의 방법에 따라 제조되는 피치아 파스토리스(Pichia pastoris) JW501 균주. Pichia prepared according to the method of claims 1 or 2 pastoris ) JW501 strain. 제4항 기재의 피치아 파스토리스(Pichia pastoris) 형질전환체를 이용한 치료 단백질의 소장 전달방법. Pichia as described in claim 4 pastoris ) Small intestine delivery method of therapeutic protein using transformants.
KR1020070103666A 2007-10-15 2007-10-15 A method of intestinal delivery of therapeutic proteins using conditional suicide of genetically modified microorganisms KR100980411B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020070103666A KR100980411B1 (en) 2007-10-15 2007-10-15 A method of intestinal delivery of therapeutic proteins using conditional suicide of genetically modified microorganisms

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020070103666A KR100980411B1 (en) 2007-10-15 2007-10-15 A method of intestinal delivery of therapeutic proteins using conditional suicide of genetically modified microorganisms

Publications (2)

Publication Number Publication Date
KR20090038260A true KR20090038260A (en) 2009-04-20
KR100980411B1 KR100980411B1 (en) 2010-09-07

Family

ID=40762535

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020070103666A KR100980411B1 (en) 2007-10-15 2007-10-15 A method of intestinal delivery of therapeutic proteins using conditional suicide of genetically modified microorganisms

Country Status (1)

Country Link
KR (1) KR100980411B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014119956A1 (en) * 2013-01-31 2014-08-07 Hanmi Pharm. Co., Ltd. Recombinant yeast transformant and process for preparing immunoglobulin fc fragment employing the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2101610A1 (en) 1992-08-07 1994-02-08 William D. Prevatt Production of bacillus entomotoxins in methylotrophic yeast
US6258559B1 (en) 1999-03-22 2001-07-10 Zymogenetics, Inc. Method for producing proteins in transformed Pichia
KR100594607B1 (en) * 2004-11-03 2006-06-30 재단법인서울대학교산학협력재단 Probiotic microorganisms producing human growth hormone fused with Fc fragment of human IgG for oral delivery system and a method for producing the same

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014119956A1 (en) * 2013-01-31 2014-08-07 Hanmi Pharm. Co., Ltd. Recombinant yeast transformant and process for preparing immunoglobulin fc fragment employing the same
US9394546B2 (en) 2013-01-31 2016-07-19 Hanmi Pharm. Co., Ltd Recombinant yeast transformant and process for preparing immunoglobulin Fc fragment employing the same

Also Published As

Publication number Publication date
KR100980411B1 (en) 2010-09-07

Similar Documents

Publication Publication Date Title
AU2018315371B2 (en) Recombinant antibody having unique glycan profile produced by CHO host cell with edited genome and preparation method thereof
KR102056651B1 (en) Pichia ciferrii cells and use thereof
CN111601895B (en) Promoter polynucleotide, signal polypeptide and uses thereof
KR20220131513A (en) Extracellular vesicle-based agents and methods for the treatment of neuropathic diseases
KR20060079239A (en) Methods, kits, and composition for the development and use of monoclonal antibodies specieic to antigens traditionally of low immunogenicity
KR100980411B1 (en) A method of intestinal delivery of therapeutic proteins using conditional suicide of genetically modified microorganisms
KR20080048068A (en) Dengue virus capsid protein which induces a protective response and pharmaceutical composition
Kimball et al. Purification and characterization of eukaryotic translational initiation factor eIF-2B from liver
Spaniol et al. Complexome profiling on the Chlamydomonas lpa2 mutant reveals insights into PSII biogenesis and new PSII associated proteins
US6329157B1 (en) Antigen cocktails and uses thereof
Kirwan et al. Vaccinia virus modulation of natural killer cell function by direct infection
CN112680477B (en) Seamless cloning technology-based H9N2 subtype avian influenza virus rescue method
Hickson et al. Quantification of SNARE protein levels in 3T3-L1 adipocytes: implications for insulin-stimulated glucose transport
RU2795160C1 (en) HYBRID GENE CONSISTING OF THE RBD RECEPTOR OF THE SURFACE PROTEIN S OF SARS-CoV-2 CORONAVIRUS, S14P5 AND S21P2 EPITOPES, Fc FRAGMENT, FOR OBTAINING A RECOMBINANT ANTIGEN AND ITS USE AS PART OF A VACCINE COMPOSITION AGAINST CORONAVIRUS INFECTION
FUTATSUGI et al. Muscle-specific mRNA isoform encodes a protein composed mainly of the N-terminal 175 residues of type 2 Ins (1, 4, 5) P3 receptor
CA2543789A1 (en) Detection of mutations in a gene associated with resistance to viral infection, oas1
CA2333598C (en) Toxoplasma gondii antigens, p35, and uses thereof
Mullin et al. Interaction of rat poly (A)-binding protein with poly (A)-and non-poly (A) sequences is preferentially mediated by RNA recognition motifs 3+ 4
KR20190096910A (en) Vaccine vector for porcine epidemic diarrhea virus(pedv) inducibly expressed under bile acid, transformed recombinant lactic acid bacteria and manufacturing method thereof
KR101731837B1 (en) Recombinant plasmid for screening inhibitors of ompA expression
Kulemzin et al. Characterization of human FCRLA isoforms
CN114008195A (en) Novel mechanisms for controlling RNA viral replication and gene expression
KR101901990B1 (en) Vector replicable both in E.coli and lactic acid bacteria cell, cell including the vector, and method of using the cell
CN104073511A (en) Bovine lactoferricin peptide constitutive type yeast expression vector and preparation method thereof
KR102251603B1 (en) Composition for prevention and treatment of mycoplasma hyoriasis infection and method for producing the composition

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
N231 Notification of change of applicant
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130816

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20140722

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20150730

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20160212

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20170724

Year of fee payment: 8